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Zusammenfassung
Während der Bestrahlung von Prostata- und Lungentumoren kann die intrafraktionelle Or-
ganbewegung erheblich sein. Wie sich diese Bewegung klinisch auf einzelne Patienten und
Patientenkollektive auswirkt ist noch Gegenstand aktueller Forschung. In der vorliegenden
Arbeit wurden für diesbezügliche Untersuchungen Echtzeitbewegungsdaten implantierter
Transponder verwendet, die mittels eines elektromagnetischen Tumorortungssystems wäh-
rend zweier am dkfz durchgeführter klinischer Studien erhoben wurden. Für beide Tumor-
entitäten wurde zunächst die auftretende Bewegung charakterisiert und quantifiziert. Dar-
auf aufbauend wurden für die Prostatabestrahlungen Untersuchungen zu den Auswirkungen
dieser Bewegung auf Sicherheitssäume und eine experimentelle und rechnerbasierte Quan-
tifizierung der dosimetrischen Konsequenzen für Patienten auf individueller Basis durchge-
führt. In einer ersten klinischen Studie zur elektromagnetischen Tumorortung in der Lunge
standen die Quantifizierung inter- und intrafraktioneller Veränderungen der Transponder-
geometrie durch Atembewegung und Tumorschrumpfung im Mittelpunkt. Zusätzlich wurde
die Korrelation zwischen interner Lungentumorbewegung und externer Brustkorbbewegung
untersucht. Die Ergebnisse führen zu der Schlussfolgerung, dass eine Echtzeitüberwachung
der internen Bewegung für beide Tumorentitäten notwendig ist, um eine Reaktion auf die
Bewegung zu ermöglichen und so die resultierenden dosimetrischen Konsequenzen zu re-
duzieren, im Besonderen wenn eine hypofraktionierte Therapie durchgeführt wird. Für die
Lungenpatienten ist es zusätzlich erforderlich die interne Tumor- und Transpondergeometrie
mit Hilfe einer regelmäßigen Kontrollbildgebung zu überprüfen.
Abstract
It is well known, that intrafractional tumor motion can be remarkable in prostate and lung
radiotherapy, but the clinical impact on single patients and patient populations is still un-
der investigation. In this work, real-time motion data of implanted transponders gathered
with an electromagnetic tumor tracking system during two clinical trials performed at dkfz
was used for evaluations concerning this matter. For both tumor entities the occurring mo-
tion was characterized and quantified, first. Based on this data, investigations for prostate
radiotherapy deal with implications of this motion on the size of safety margins and the
experimental and computational quantification of dosimetric consequences for individual
patients. In this first clinical trial on electromagnetic tumor tracking in lung, analyses
focused on the quantification of inter- and intrafractional variations of the transponder ge-
ometry due to breathing motion and tumor shrinkage. Additionally, the correlation between
internal measured lung tumor motion and external chest motion was assessed. According
to our results, we conclude that real-time monitoring of the internal motion is necessary
for both tumor entities to enable motion management reducing dosimetric consequences, in
particular if a hypofractionated radiotherapy is applied. For lung patients it is additionally
required to perform a regular control of internal tumor and transponder geometry through
patient imaging.
v
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1 Introduction
In radiotherapy, it is crucial to irradiate the pre-defined target volume, mostly a tumor, as
precisely as possible. Firstly, to guarantee the curative effect of the therapy by irradiating
the whole tumor with a sufficient radiation dose to kill all tumor cells. Secondly, to avoid
side effects caused by the irradiation of healthy tissue and especially organs at risk that are
in close proximity to the tumor.
In the last decade, many improvements in treatment planning algorithms and treatment
delivery techniques have been made to enable the optimization and delivery of a tumor
conformal dose distribution even for complex geometries, where e.g. the tumor surrounds
healthy organs. These therapy options are for example intensity modulated radiation ther-
apy (IMRT), arc therapy or radiotherapy with protons or heavy ions. Modern treatment
devices can deliver these complex dose distributions containing steep dose gradients with
an accuracy of approximately 1mm in a phantom. However, expected changes in patient
geometry during the irradiation (called intrafraction motion) and from day-to-day (called
interfraction motion) cause the delivered dose distribution in a patient treatment to be differ-
ent from planned. Furthermore, the definition of the clinical target volume is an additional
source of uncertainty.
The detection, quantification and dosimetric consequences of inter- and intrafraction tumor
motion are the topic of this thesis. Tumor motion can distort the delivered dose distribution
mainly in two ways. Systematic shifts of the target volume lead to a shifted dose and random
motion components induce a blurring of the applied dose distribution compared to the
planned one. In general, there are two concepts of motion consideration in radiotherapy.
Firstly, estimated motion, e.g. based on a similar patient population or on some motion
data of the patient itself can be used during the treatment planning process. Secondly the
treatment can be adapted during the treatment delivery process using current measured
tumor position. The classic treatment planning based approach is to avoid an underdosage
of the tumor by an enlargement of the high-dose volume, called margin concept. This
method leads to an irradiation with therapeutic dose of some healthy tissue in the vicinity
of the tumor, which can cause severe side effects. When an adaptive treatment approach
is used, these margins can be reduced, but not omitted because of persisting sources of
uncertainty.
The most widely used method of integration of current tumor position information in daily
treatment delivery is the use of image guidance for patient positioning prior to each fraction.
With this technique, e.g. realized by the acquisition of a cone beam computed tomography,
most interfraction changes can be detected. The compensation possibilities range from direct
repositioning of the patient to a replanning process, which will be available even online in
the near future. More complex is the detection and management of intrafraction motion. An
adaption of the treatment to intrafraction motion, like irradiation in a window of predefined
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tumor positions only (called gating) or the active motion compensation either by moving the
beam or the patient (called tracking) ideally need real-time information of tumor motion.
This real-time information could be achieved via imaging methods as well, but these methods
are often accompanied with an additional radiation dose to the patient or need a dedicated
treatment device, like the MR-linac, which is still under development. To monitor breathing
motion for the management of lung tumor motion, it is also common to use an external
surrogate like chest motion to detect the current breathing phase. Treatment adaption
using this external information has to rely on a stable relation between external motion
and internal tumor motion, which is needed to check during the treatment, for example
by frequent imaging. Another method for real-time monitoring of tumor motion without
additional imaging dose providing sub-millimeter accuracy is electromagnetic tracking of
implanted transponders, as used here.
Patient data from two clinical trials is used for the investigations in this thesis. Real-time
motion data was obtained with the Calypso tumor tracking system by Varian Medical Sys-
tems Inc. for prostate patients in the first trial and for lung patients in the second one. For
the prostate patients, the motion amount was quantified and two different evaluations were
made based thereon: first, margins which would be sufficient to compensate this motion in
different treatment scenarios were calculated using a population based approach. Second,
a dose recalculation was made using the individual patient motion data together with the
delivered treatment plans to evaluate the dosimetric consequences of the measured motion
in combination with the dkfz margin concept. The lung trial was a multi-center trial or-
ganized by Varian for the clinical evaluation of newly developed lung transponders. The
obtained data was used for quantification of motion amount and characterization of motion
patterns to evaluate the potential of different motion management methods. The stability
of the transponder geometry in lung tissue was evaluated on an intra- as well as on an
interfractional basis to derive demands on the planned implantation geometry and the need
of geometry checking during a course of treatment. Additionally, for three patients concur-
rent chest motion data could be collected and the correlation between internal transponder
motion and external chest motion was investigated to evaluate for example phase shifts
between the signals and inter- and intrafractional changes in correlation strength.
The thesis is organized as follows:
• Chapter 2 gives an overview of the treatment procedure applied to the patient in
photon radiotherapy and of tumor motion and its consequences. The chapter then
focuses on a detailed description of motion detection and management methods in
radiotherapy.
• Chapter 3 presents the investigations made for intrafraction motion in prostate ra-
diotherapy. The measured prostate motion is quantified and suitable margin sizes
for different treatment scenarios are determined. Furthermore the dosimetric conse-
quences of the found prostate motion is estimated. Three dose recalculation methods
were tested, and after an experimental validation, one of it was applied to the patient
data.
• Chapter 4 deals with the new application of electromagnetic tracking in lung radio-
therapy. Investigations on motion amount, reliability of transponder geometry and
correlation between internal lung and external chest motion are presented.
• Chapter 5 gives a conclusion on the obtained results.
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2 The motion problem in high precision
radiotherapy
The success of radiotherapy is dependent on the ability to deliver a sufficient amount of
energy dose to the whole target region. This aim is restricted by the concurrent irradiation
of healthy tissue, leading to side effects, in particular in organs at risk in the neighborhood
of the target. Several techniques for treatment delivery as well as imaging and treatment
planning were developed to achieve this goal. The first part of this chapter will give an
overview with a focus on techniques, which are used for treatments analyzed in this thesis.
The effect of radiotherapy is based on the deposition of energy by ionizing radiation. This
energy dose D is defined as the absorbed energy dE per irradiated mass dm (D = dEdm). The
ionizations can lead to DNA damage like double strand breaks and thereby to the death of
irradiated cells. The organs at risk are protected against cell death by two aspects: first they
are spared from radiation dose and second the radiation is delivered in several small parts
(called fractions) over weeks in most cases. The latter technique, known as fractionation,
uses the fact that healthy tissue has a larger ability to repair DNA damage, than tumor
cells, so the healthy tissue can regenerate more between radiation fractions (Sauer, 2010).
Treating a patient with radiation will always contain the consideration of patient positioning
and organ motion. In the treatment planning process, the tumor position within the patient
is typically known from a computed tomography (CT) data set. Magnetic resonance imaging
(MRI) and positron emission tomography (PET) can further be used for classification of
the disease and for refinement of the tumor volume definition. Despite the use of all these
imaging modalities, the definition of the target volume is one of the largest uncertainties in
radiation therapy (Van de Steene et al., 2002; Rasch et al., 2005). Besides from that, this
image data is only a snap-shot of the patient anatomy at the time of treatment planning.
Even 4D-CT techniques for lung patients cover typically only a few breaths, to study the
motion induced by breathing. The second part of this chapter describes causes of deviations
between the actual treatment situation from this snap shot, their dosimetric consequences,
as well as strategies to detect, avoid and compensate for them.
There are several types or radiation sources available for radiotherapy, providing different
particles in various energy ranges, like electrons, photons, protons and heavy ions. All
these particles have advantages and disadvantages regarding their use for patient treatment.
In this thesis photon radiotherapy is considered only, as the vast majority of treatments
worldwide are performed with photons.
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2.1 The key components of modern radiotherapy
2.1.1 Imaging and treatment planning
After the clinical decision of performing a radiotherapy for a particular patient, image data of
the patient has to be acquired for treatment planning. It is required that the patient setup in
these images is as close as possible to the treatment setup. For example, this can be achieved
by using the same positioning devices, like foot or arm rests. Additionally, these and other
devices provide vital patient immobilization during image acquisition. The planning process
itself, i.e. the optimization of treatment parameters like beam shapes and irradiation amount
per beam and the dose calculation is done on a computed tomography (CT) data set. From
the CT the spatial distribution of electron densities in the patient can be extracted, which is
needed as basis for dose calculation as described in section 3.2.2.1. Depending on the tumor
site additional magnetic resonance imaging (MRI) and/or positron emission tomography
(PET) can be performed for better knowledge of the tumor position, volume, stage or
affected lymph nodes. Thereby the MRI can provide morphological information because of
the better soft tissue contrast in comparison to a CT while functional MRI and PET can
provide biological information such as tumor metabolism.
For tumors moving with respiration, especially lung tumors, it is common to acquire an
additional 4D CT data set (Vedam et al., 2003; Keall et al., 2004). During this acquisition
the external breathing motion is detected and recorded, for example using a chest belt,
see section 2.2.2.3. This external signal is analyzed regarding the periodic breathing cycle.
After that the complete CT data set is binned according to the breathing cycle phase in
which it is acquired. From this sampled data up to 10 CT image sets each representing
a single breathing phase are reconstructed. This can be done using a time (phase) or an
amplitude binning of the data. The first method assigns the breathing phase according to
the percentage of whole cycle time, that has elapsed until the start of the current cycle.
The second one uses the amplitude of the external signal for phase assigning. If this is
done relative to the maximum amplitude of each breathing cycle, it can have advantages in
comparison to the phase binning for complex breathing patterns (Wink et al., 2006).
For dose prescription and calculation, different volumes have to be delineated in the plan-
ning CT (ICRU, 1993). Considering MRI and PET information, if available, the gross
tumor volume (GTV) is defined as the visible tumor. A larger volume around the GTV,
called clinical target volume (CTV) is delineated based on knowledge of tumor site specific
microscopic tumor infiltration into the healthy tissue. In radiotherapy of lung tumors the
CTV is often replaced by an ITV (internal target volume (ICRU, 1999)). This ITV is com-
monly created by a fusion of all CTVs determined in all phases of the planning 4D CT, so
it already contains the respiratory induced motion, that was present during the planning
CT. Depending on tumor site and treatment delivery technique additional larger volumes
around the CTV or ITV, called planning target volume (PTV), can be defined to account
for tumor motion and other geometrical uncertainties in the dose calculation or delivery. A
deeper introduction to these margin concepts is given in section 2.2.3.2.
After the delineation of the organs at risk different dose levels have to be specified. De-
pending on the tumor site a specific dose is prescribed to the target volume and maximum
doses for the healthy organs are defined. At this point a treatment planning program is
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used for dose calculation and optimization of beam parameters, while conforming to the
predetermined normal tissue dose constraints and PTV prescription dose as much as pos-
sible. The optimization can be performed by manually adapting beam shapes and weights
for conventional 3D conformal therapy (3D-CRT) or by an inverse optimization software via
user defined constraints and penalty factors weighting deviations between calculated and
prescribed dose distribution for intensity modulated radiotherapy (IMRT), see (Bortfeld
and Thieke, 2006).
For a description of radiotherapy planning for different tumor sites see (Barrett et al.,
2009).
2.1.2 Dose delivery
All patient treatments considered in this thesis are performed with the same treatment
device, but with two different techniques of beam delivery. This section gives a short in-
troduction in the generation of irradiation, the used coordinate system and beam delivery
geometry. Details of the performed treatments can be found in sections 3.2.1 and 4.2.1 for
prostate and lung patients, respectively.
2.1.2.1 Treatment device
All patient treatments analyzed in this thesis as well as the experiments are performed
with a Siemens Artiste treatment device, equipped with a 160 MLC (Siemens AG, Munich,
Germany). The main components and geometrical aspects of a medical linear electron
accelerator can be seen in fig. 2.1(a). For all applications used in this work, electrons are
accelerated to an energy of 6MeV. These electrons are then directed to a target made of
tungsten, where bremsstrahlung and characteristic X-ray radiation is produced. To form a
radiation field with homogeneous fluence, the spatial fluence distribution is then flattened
by the transition of a flattening filter, which is mainly a cone-shaped piece of tungsten.
The resulting photon spectrum has a maximum energy of 6MeV and a mean energy of
about 2MeV, depending on the distance from the central beam axis (Sheikh-Bagheri and
Rogers, 2002; Faddegon et al., 2004). The beam aperture is then formed by a multi leaf
collimator (MLC), made of tungsten as well. To create a large number of possible beam
directions relative to the patient, the whole linear accelerator gantry can be rotated around
the patient and the patient couch can be rotated around the vertical room axis corresponding
to the central axis of a vertical beam. The point were the rotation axes intersect is called
isocenter of the treatment machine, see fig. 2.1(a). The beam source-to-isocenter distance
is 1m. The maximum size of the irradiation field is 40× 40 cm2 in the isocentric distance.
The 160 leafs of the MLC are arranged in opposing pairs, while each leaf pair can block a
radiation stripe with a width of 0.5 cm in the isocentric plane.
All descriptions and results presented in this thesis use the IEC-61217 coordinate system.
The axes are shown in fig. 2.1(b). In general the three terms lateral, longitudinal and vertical
direction are used. They are always according to a patient lying on the treatment couch on
his back with the head near the gantry, this position is called ‘head first supine’ (HFS).
7
Chapter 2. The motion problem in high precision radiotherapy
(a)
x: lateral 
y: longitudinal 
z: vertical 
(b)
Figure 2.1: (a) Scheme of a medical electron linear accelerator in photon irradiation mode,
taken from (Podgorsak and International Atomic Energy Agency, 2005) (b) Draft of the used
coordinate system IEC 61217, the point of origin is the isocenter.
2.1.2.2 Dose delivery techniques
The mechanical abilities of the treatment machine can be used in different ways to reach
an optimal dose coverage of the target with concurrent sparing of the organs at risk. They
differ in the workload and time for therapy planning and delivery. The technique is chosen
due to the tumor site and geometrical properties of the patient anatomy. All treatments
analyzed in this thesis are performed either as a 3D conformal or a step-and-shoot intensity
modulated radiation therapy.
• 3D conformal radiation therapy (3D-CRT):
Performing three-dimensional conformal radiotherapy is a very intuitive way of irra-
diating a target volume. Initially, for each beam the aperture formed by the MLC is
defined as the projection of the target shape to this beam angle. Then an adjustment
to the beam shapes and weights and dose per beam is either manually or automatically
optimized. The radiation delivery is organized as follows: for each beam the gantry
moves to the planned position, the MLC forms the aperture, the radiation is delivered
and the gantry moves to the next beam angle.
• Step-and-shoot intensity modulated radiation therapy (SNS-IMRT):
The main difference to 3D-CRT is the substitution of a flat fluence distribution per
beam by a heterogeneous fluence modulated beam, called an ‘intensity modulated’
beam. This is achieved by consecutive application of overlapping beam apertures
formed by the MLC. Each one of these beam apertures is called an IMRT segment,
while the whole irradiation amount from one beam angle is called a radiation field.
The fluence pattern for each beam is thereby optimized using an inverse treatment
planning software. The possibility to form complex fluence profiles per beam can lead
to a more conformal tumor dose while sparing of organs at risk for complex patient
geometries compared to 3D-CRT. In particular, the opportunity to form concave dose
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distributions can be important e.g. in the treatment of tumors in the brain or spinal
region. For a review on IMRT see (Bortfeld, 2006).
In a clinical setting, it is common for both techniques to manually select the number of
beams and the gantry angles while considering the geometry of target volume and organs at
risk. There are up to 10 beam angles defined, usually. For each part of radiation delivery of
3D-CRT and SNS-IMRT the beam angle and beam aperture are adjusted, before the beam
is enabled, so there are no moving parts of the treatment device during actual irradiation.
Obviously the duration of each treatment depends on the prescribed dose and the complexity
of the patient case, leading to a different number of beams or IMRT segments. Typical
fraction times from start of first beam to end of last beam including all gantry and MLC
motion for the treatments analyzed in this thesis are about 5min for 3D-CRT and about
10min for SNS-IMRT.
2.2 Motion management in radiotherapy
2.2.1 Organ motion and its dosimetric impact
2.2.1.1 Motion types
In the vast majority of cases, a radiotherapy treatment is fractionated into several irradia-
tions on different days. Depending on the tumor site and tumor stage, different fractionation
schemes can be applied. Standard fractionation schemes often contain 30 to 35 fractions
typically given over six to seven weeks, five times a week. Most treatments analyzed in
this thesis are fractionated this way. Another fractionation scheme occurring in this thesis
is the hyofractionation, where less fractions with higher fraction doses are prescribed. The
hypofractionated treatments here are given in 10 fractions, 5 times a week. All these frac-
tionation schemes lead to two different types of deviations from the situation, which was
present at the time of treatment planning. These different types are called interfraction and
intrafraction motion, described in the following:
• Interfraction motion summarizes all geometric deviations from fraction to fraction.
This contains an inaccurate positioning of the whole patient with respect to the ra-
diation source, as well as internal anatomy changes. These changes can appear due
to physiological processes like digestion (e.g. different filling of digestive organs) or as
response to the therapy, such as tumor shrinkage or a decrease of body-fat volume.
• Intrafraction motion is the motion occurring during one treatment fraction, typi-
cally lasting 5min to 15min. Intrafraction motion is mostly caused by organ motion
on a short time scale like breathing or digestion. Digestion for example can lead to
a changing bladder or colon filling. In addition, there can be motion due to different
muscle tense of the patient, e.g. a continuous relaxation with increasing treatment
time.
9
Chapter 2. The motion problem in high precision radiotherapy
(a) Systematic (b) Random
Figure 2.2: Schematic of dosimetric consequences of systematic (a) and random (b) errors
in radiotherapy treatments. For simplification, the static case is defined as a circular shaped
target region (black circle) covered by a perfect fitting homogenous dose (blue area), shown on
the left side of each figure. Assuming a systematic 2-dimensional shift of the actual relative to
the planned target region, the dose distribution will be shifted and parts of the target will be
not irradiated while some healthy structures are irradiated with the therapeutic dose (a). If an
equally distributed 2-dimensional random displacement of the target is considered, there will be
an inner region of the target getting the planned dose, while in the outer region the dose will
decrease continuously leading to an underdosage of the tumor edge and an overdosage in the
healthy vicinity of the target (b).
2.2.1.2 Motion effects on delivered dose distributions
Inter- and intrafractional motion can cause large deviations between the planned and the
delivered dose distribution. Both motion types can have random and systematic components
leading to different effects on the dose distribution as can be seen in fig. 2.2. In the following,
the circumstances and dosimetric consequences of these permanent or temporary errors of
geometric relation between irradiation field and target volume are described for the case of
no motion management. The terminology follows (van Herk et al., 2000).
• Systematic errors
Systematic errors are usually defined as errors due to inaccuracies in treatment prepa-
ration, e.g. in target definition or selection of landmarks for patient positioning. They
are called systematic when they have the same influence on every fraction of the treat-
ment for one single patient, while they are different for two patients. These errors
cause a shift of the dose distribution, as can be seen in fig. 2.2(a). Intrafraction mo-
tion can have a systematic component as well, for example a continuous drift during
the irradiation, if this drift is always towards the same direction.
• Random errors
Random positioning errors and motion lead to a blurred dose distribution, as depicted
in fig. 2.2(b). They are usually defined as inaccuracies in treatment execution differing
from fraction to fraction, like errors in patient positioning on a day-to-day basis or
random intrafraction motion.
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These definitions are for a whole course of radiotherapy containing several fractions. Ran-
dom positioning errors convert into systematic errors, when only single fractions are eval-
uated. There can be systematic errors leading to equal effects in all patients as well, like
misalignment of the coordinate systems of the CT scanner and the therapy device. They
are not considered here, because they can be detected and avoided by quality assurance
measurements.
The methods to calculate dosimetric consequences using given patient motion data and
clinical dose distributions in this thesis are presented in section 3.2.2.2.
2.2.2 Motion detection methods
There are various techniques for patient positioning and monitoring of inter- and intrafrac-
tional motion. All these techniques have advantages and drawbacks associated with the
characteristics of acquired data and additional risks for the patients. The methods can be
categorized by the type of provided motion information in: I) image guidance, II) elec-
tromagnetic detection of internal markers and III) detection of external surrogate motion.
This section gives an overview of these methods with a detailed description of the specific
techniques used in this thesis.
2.2.2.1 Image guidance
The most widely used application of image guided radiotherapy (IGRT) is the patient posi-
tioning prior to each fraction. Established methods using the MV treatment beam with a flat
panel detector on the opposing side of the patient are 2D portal imaging (Hurkmans et al.,
2001) and megavoltage cone beam CT (MV CBCT) (Pouliot et al., 2005). For better soft
tissue contrast, kV X-ray imaging can be performed with one or more X-ray sources and as-
sociated flat panel detectors mounted on the linac gantry itself or elsewhere in the treatment
room. 3D information can thereby be extracted from concurrent 2D imaging with at least
two source-detector combinations (Fu and Kuduvalli, 2008; Jin et al., 2008), or a kilovoltage
cone beam CT can be acquired with a linac mounted system (Jaffray et al., 2002). Using
dedicated software tools, an estimation of 3D translations and rotations of the prostate can
be made even from 2D projections of a single KV source, (Poulsen et al., 2008; Tehrani
et al., 2013). Image guidance without additional imaging dose to the patient is possible
using ultra sound or MRI. Established methods are an ultra sound probe for 2D-imaging
(Lattanzi et al., 2000) and a combination of 2D imaging with infrared based tracking of the
probe, leading to information in 3D (Johnston et al., 2008). Treatment machines with an
integrated MRI are now available for irradiation with photons from 60Co decay (ViewRay,
ViewRay Incorporated, Oakwood Village, Ohio), but still under development for photon
therapy based on electron linear accelerators (Lagendijk et al., 2008; Fallone et al., 2009).
Some of these methods can be used for monitoring of intrafractional motion as well. The
aforementioned 3D volumetric imaging with the treatment beam or a kV source (CBCT)
needs a complete or at least half a rotation of the imaging system around the patient with
rotation times around 1min impeding the application during the therapy. Continuous MV
portal imaging, which is the detection of the therapeutic radiation field behind the patient
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Figure 2.3: Photograph of the Siemens Artiste.
The MV flat panel is extended and the gantry
is slightly rotated. The treatment couch can be
seen in the front.
and therefore not accompanied with additional dose, is able to monitor motion perpendicular
to the beam direction, if fiducial markers are implanted (Berbeco et al., 2007), or even
without markers for lung tumors (Rottmann et al., 2010). Combining two or more beam-
detector combinations with different beam angels to a stereoscopic system, 3D-motion can
be extracted, too (Berbeco et al., 2004), but with additional dose. An ultra sound probe can
be used for continuous 2D imaging with the possibility of 3D motion estimation (Hsu et al.,
2005), but stable acoustic coupling has to be guaranteed. A continuous full 3D imaging
during irradiation is possible with an integrated MRI system as mentioned above.
Megavoltage cone beam CT (MV CBCT) In this thesis, MV CBCT data sets acquired for
patient positioning prior to each fraction for all prostate patients are used. They are acquired
with the Siemens Artiste treatment beam with a 6MV photon spectrum, see section 2.1.2.1.
Figure 2.3 shows the Siemens artiste with extended flat panel detector. The technique of
acquiring a CT using a broad beam and a flat panel detector is called cone beam CT, because
of the beam shape covering the whole imaged region in one rotation. The term ‘cone beam
CT’ is in contrast to a conventional diagnostic CT which is called ‘fan beam CT’ because
of a narrow beam and detector performing a spiral path with hundreds of rotations around
the patient. To reduce scan time and hence motion artifacts, current developments in
diagnostic CTs go towards broader beams and increasing number of detector rows as well
as rising rotation speed (e.g. Aquilion One, Toshiba Corporation, Tokyo, Japan).
Imaging with the MV treatment beam leads to less soft tissue contrast in comparison to a kV
X-ray source, which have typically mean photon energies below 100 keV. The tissue contrast
in photon imaging methods is driven by tissue dependent attenuation of the beam, detected
behind the patient. This attenuation can be described by the reduction in the photon
beam intensity I behind a material of thickness d with a linear attenuation coefficient µ:
I(d) = I0 · e−µ·d, with the initial intensity I0. The linear attenuation coefficient is the sum
of the attenuation coefficients from all interaction types. In the energy ranges used here,
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only the photo electric and the Compton effect have to be considered. In kV imaging the
photoelectric effect is dominant, while in MV imaging the Compton effect is most important.
This is mainly driven by the dependence of the photoelectric effect on the photon energy Eγ ,
namely µphoto electric ∝ 1/E3γ . The contrast in the images is mainly achieved due to different
atomic numbers Z of the tissues. For the photo electric effect the attenuation coefficient
shows a strong dependence on Z (µphoto electric ∝ Z3 to 4) while for the Compton effect this
dependence is much weaker (µCompton ∝ Z). These conditions enable excellent opportunities
for tissue differentiation in the human body for kV imaging, while in MV imaging their is
nearly no soft tissue contrast. As a result patient positioning with an MV CBCT relies
mainly on the bony anatomy, which can be distinguished from soft tissue due to a large Z
difference, or on implanted fiducial markers, which are often made of gold.
2.2.2.2 Electromagnetic methods
Electromagnetic devices for patient positioning and motion monitoring deliver 3D position
information with high update rates without imaging dose or the need of information ex-
traction from image data. Two different systems are available, the Calypso Tumor Tracking
System by Varian Medical Systems Inc., Palo Alto, CA and the RayPilot System by Micro-
pos Medical AB, Gothenburg, Sweden (Shah et al., 2011b), while only the first is approved
for clinical usage outside patient trials. Both systems are designed for reporting the co-
ordinates of one special point in the patient over time. Thus, the main drawback of this
technique is the absence of information about the current anatomic situation e.g. relative
position of target and organs at risk or deformations of the target. Both systems work via an
antenna array detecting resonant circuits within the patient. The main difference is the use
of three implanted passive resonant circuits, which remain in the body after the therapy for
the Calypso System and the use of one active cabled resonant circuit in a catheter, which
is removed after the course of therapy for the RayPilot System. Both are developed for
application in the prostate. But for the Calypso System removable skin transponders for
fixation everywhere on the body were already approved for clinical use in the US and the
EU and lung transponders are approved for clinical use in the EU and for investigational
use in the US.
The Calypso System In this thesis, motion data detected by the Calypso System is used.
This data was acquired for prostate and lung cancer patients during all treatment fractions.
General system description follows the Calypso users manual (Calypso Medical Technologies,
Inc., 2010a) and (Balter et al., 2005). Information about lung application refers to (Calypso
Medical Technologies, Inc., 2010b).
A schematic of the device components can be seen in fig. 2.4, where a prostate case is shown.
The only difference to lung application is the use of different transponders, called beacons.
The transponders used for prostate implantation, shown in fig. 2.5(a), are implanted en-
dorectally. The lung cancer patients get their transponders implanted bronchoscopically, a
schematic of a lung beacon is shown in fig. 2.5(b). The electronic part of both beacon types
is the same, but the lung beacons have a special capsule with nitinol legs, which are extended
for fixation of the beacon in the specified air way close to or inside the tumor. This fixation
capsule is necessary because smooth surface beacons show an insufficient fixation rate, see
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Figure 2.4: Overview of the components of the Calypso Tumor Tracking System, taken from
(Calypso Medical Technologies, Inc., 2010b), with permission.
(Shah et al., 2013). The beacons are passive resonant circuits with three different resonance
frequencies close to 300, 400 and 500 kHz, respectively. An antenna array is placed above the
patient to localize the beacons in the patient. For this localization, the array is equipped
with four source coils emitting electromagnetic waves with frequencies between 275 and
550 kHz consecutively and in periodic repetition. The beacons are excited corresponding
to their individual resonance frequency. During periodic pauses of the exciting signal the
frequency and strength of each beacon’s emission is detected by 32 receiver coils placed
all over the array for determining the individual beacon position relative to the array. We
used the Calypso System version 2.0 in which each individual beacon is detected approxi-
mately every 300ms. From these positions, the beacon centroid position is calculated and
updated every 100ms, when a new beacon position is known. The mobile array has nine
active infrared markers integrated in its surface. They are tracked with infrared cameras,
mounted permanently on the ceiling of the treatment room. Because of this combination,
the position of the beacons and the beacon centroid relative to the fixed coordinate system
of the treatment room is known.
During the treatment planning process, the planning CT is used to define the position of
the treatment isocenter inside the patient and to read out the coordinates of the implanted
beacons relative to it. This information is then transferred to the Calypso System. During
the treatment fractions, the deviation between actual and planned position for only one
point inside the patient is shown on the tracking station monitor and can be used for
motion management. The geometry of the beacons and the defined isocenter constitutes
this point and thereby the localization mode in which the system is operating. There
are two localization modes, the centroid mode and the isocentric mode. Depending on the
special beacon geometry in each patient, a maximum distance between the isocenter and the
beacon centroid is allowed for the use of isocentric localization. If this distance is exceeded,
the centroid mode is chosen and the displayed distance refer to the centroid’s actual and
planned position. Otherwise, the isocentric mode is chosen and the measured centroid
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(a) (b)
Figure 2.5: Photograph of a transponder as used for the prostate patients: length 8mm,
diameter 1.85mm (a). Draft of an encapsulated transponder for use in lung patients: length
with legs 14mm, diameter with retracted legs 2mm and with extended legs 5.5mm. Taken from
(Calypso Medical Technologies, Inc., 2010b), with permission. (b)
deviation is converted into a deviation of the current and planned isocenter position. These
two deviations are not identical, when rotations between the current and planned patient
geometry occur. In such a situation, a determined translation is correct for the center
of rotation defined by the coordinate system, only. This center of rotation is the beacon
centroid. Considering the rotation angles around all three axes, measured in the beginning
of each fraction, the centroid deviation can be converted into an isocentric deviation. This
conversion assumes a rigid body, due to that it is done for small distances between beacon
centroid and isocenter, only. The localization mode is relevant for some investigations
presented in this thesis, there it will be referred to it, elsewhere the used term will be simply
‘prostate motion’ or ‘target motion’.
The Calypso System is equipped with a detector, measuring scattered radiation outside
the treatment field. The beam status (on or off) is measured with 10Hz update rate,
corresponding to the displayed target motion. For further analysis, all data is stored with
a time stamp, including the beam status and the individual beacon positions.
The accuracy of the Calypso System in clinical use is declared as sub millimeter by the man-
ufacturer (Calypso Medical Technologies, Inc., 2010a) for a localization volume beginning
8 cm below the array with 14 cm width and length and 19 cm height. Evaluations in air and
saline results in an accuracy (distance from predefined position) of < 0.2 mm for the whole
volume, while the reproducibility (read out stability) was very dependent on the vertical
beacon-array distance with values up to 0.01mm for a distance of 8 cm at the upper border
of the localization volume and up to 0.62mm in 27 cm distance at the lower border of the
localization volume (Balter et al., 2005). Because of that the volume declared as usable for
intrafraction motion monitoring is 14 cm wide and long, but reaches from 8 cm beacon-array
distance until 21 cm, only.
In cooperation with the junior group computer assisted interventions at the dkfz, we per-
formed measurements of the precision and accuracy of our Calypso System using a stan-
dardized protocol, which is designed for electromagnetic tracking devices used in computer
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assisted surgery. The precision (root mean square of 150 adjacent data points without mo-
tion) ranges from 0.3mm to 0.8mm for distances between array and beacon centroid of
11 cm and 21 cm. The accuracy of the measurement of fixed 5 cm distances in horizontal
planes was determined to (0.1± 0.1)mm for all array–beacon centroid distances. This eval-
uation is accepted for publication in the Journal of Physics in Medicine and Biology (Franz
et al., 2014).
A drawback of the marker implantation besides the general risk of surgery is although
the transponders are MRI safe, they are not MRI compatible. Meaning that there are no
safety constraints on MR imaging after implantation, but the beacons cause artifacts in the
surrounding tissue. The size of these artifacts depends on the applied MRI sequence with
radii up to 1.5 cm and lengths up to 4 cm, which makes MRI unavailable for follow-up care,
see (Zhu et al., 2009) analyzing 1.5T and 3T MRI.
2.2.2.3 External surrogates
The essential drawback of all external surrogate methods is monitoring not of the tumor
itself, but of an external patient parameter, assumed to be representative for the tumor
position. The correlation between the surrogate and the tumor position is usually known
from the treatment planning CT. The general problem of all these methods is the question of
robustness of this correlation over time from the day of planning CT to the days of treatment
and during one fraction. Depending on the motion management strategy, which will be based
on the surrogate measurement, it is necessary to check the correlation model by acquisition of
imaging data with different time intervals. The advantage of all external surrogate methods
is the avoidance of additional risk for the patient due to the data acquisition, because of the
absence (or reduction) of imaging dose and invasive marker implantation.
The most widely used method is based on drawn marks on the patient’s skin. For the
classic technique of patient positioning prior to treatment these marks are aligned with
the laser coordinate system of the treatment machine and this is commonly also done for
advanced positioning methods as approximate pre-positioning. Surrogate methods can also
be used for real-time monitoring of motion during the irradiation. For example infrared
markers on the patients skin or optical LEDs on a tight vest can be detected continuously
by cameras (ExacTrac, Brainlab AG, Feldkirchen, Germany and Synchrony Respiratory
Tracking System, Accuray, Sunnyvale, CA, USA). Another method uses a scanning laser
line for acquisition of a patient surface model (Sentinel, C-RAD AB, Uppsala, Sweden). For
the investigations presented in this thesis one external surrogate motion monitoring system
is used, the Anzai belt, which is a part of the Anzai Respiratory Gating System AZ-733V
(Anzai Medical Co., Ltd, Tokyo, Japan).
The Anzai Respiratory Gating System The Anzai Respiratory Gating System is designed
for motion detection and management in radiotherapy of tumors moving accordingly to
breathing. The device performing the surrogate measurement is called the Anzai belt. It
contains a pressure sensor and gets wrapped around the patients abdomen or chest thereby
measuring the relative changes in abdomen or chest circumference due to breathing. The
sensor delivers data with an update rate of 40Hz to a PC via signal processing hardware.
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Using the dedicated software, the periodic signal of in- and exhalation can be displayed and
used on the PC. From a planning 4D-CT, during which the Anzai belt was used for binning
of the CT reconstruction phases (see section 2.1.1), the correlation between internal tumor
motion and external breathing signal is determined. The assumption that this correlation is
still valid in all treatment fractions can lead to large discrepancies between predicted tumor
position from external signal and actual tumor position, hence the correlation should be
reviewed on a regular basis. The system is designed to use the external breathing signal
for a motion management technique called ‘gating’ described in section 2.2.3.4 through a
connection between the PC and the control software of the treatment machine. In this work,
it is used for acquiring 4D CT data sets of the lung patients and for measurement of external
breathing signal during radiation therapy for 3 lung patients.
2.2.3 Motion management strategies
There are various methods to deal with inter- and intrafraction motion in radiation therapy,
differing in effort and required extra devices. The classical techniques cover motion preven-
tion strategies and concepts for enlargement of the treated volume to encompass positioning
errors or intrafraction motion (treatment margins). Another possibility is the inclusion of
probability distributions of target position directly into the optimization process (proba-
bilistic planning). More sophisticated methods that require frequent imaging or real-time
motion information are frequent repositioning, pursuit of the tumor motion with the treat-
ment beam (tracking) or irradiation triggering based on a predefined position window of the
tumor (gating).
2.2.3.1 Motion mitigation
The most intuitive way to prohibit the distortion of the planned dose distribution due to
positioning errors and intrafractional motion is the avoidance of this motion. Multiple
techniques are available for patient setup which are designed to guarantee reproducible
patient positioning and immobilization. Examples are patient specific thermoplastic masks
mounted on the treatment couch (Tryggestad et al., 2011) for treatments in the cranial and
head and neck region, or a patient specific vacuum mattress (Nevinny-Stickel et al., 2004)
for treatments in abdominal and pelvic region.
Other methods are the choice of treatment position or a dietary protocol for the patients,
with the aim of reducing digestive motion (Smitsmans et al., 2008). For tumors moving with
respiration several strategies are explored to reduce the tumor motion amplitude during
radiotherapy. The most obvious way of motion reduction is to irradiate during breath hold.
One way to ensure the breath hold is so called ‘active breathing control’ (ABC), see (Wong
et al., 1999). Thereby the patient is connected to an adapted ventilator which controls
the respiration. Using this ventilator a breath hold of the patient can be initiated and
held by closing both valves, the patients are trained to tolerate this process prior to the
therapy. Another method is the ‘deep inspiration breath hold’ (DIBH), see (Hanley et al.,
1999; Rosenzweig et al., 2000). In this method the patients are coached to follow breathing
commands for deep inhalation and breath hold. During the therapy the therapists give these
commands and the patients respiration is monitored via spirometry. The deep inhalation
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Figure 2.6: CTV (green) and PTV (red) drawn on a computed tomography slice, one of the
Calypso beacons can be seen.
breath hold has the additional advantage of reduced lung tissue density, leading to less
normal lung tissue in the radiation field compared to other breathing phases.
2.2.3.2 Treatment margins
During the treatment planning process, the target volume as well as organs at risk have
to be defined based on imaging data. Around the clinical target volume or internal target
volume (CTV or ITV, see section 2.1.1) a planning target volume is defined by adding a
margin according to (ICRU, 1993). This is a region, where no tumor cell can be assumed
under the anatomic conditions of the planning image data. It is only defined because of
the uncertainties of volume delineation, treatment delivery and anatomic and physiologic
changes between or during fractions. In fig. 2.6 a CTV and a PTV contour can be seen
drawn in a transversal CT slice of a prostate patient. This margin leads to an enlargement of
the irradiated volume, and due to that, to a higher radiation dose in parts of organs at risk.
Thus these margins should be kept as small as possible to prevent radiation induced side
effects. The margins calculated from collected motion data in this thesis are all CTV-to-
PTV margins for the compensation of positioning errors or intrafraction motion for prostate
irradiation.
The determination of an appropriate CTV-to-PTV margin is commonly not based on motion
data from the individual patient but from population based data. This is because of the
absence of information about the individual motion prior to therapy. There are various
publications about a reliable method of margin determination, for a review see (van Herk,
2004).
The most widely used method is based on (van Herk et al., 2000). They calculated his-
tograms of CTV coverage probability depending on systematic and random errors in treat-
ment preparation and execution. To derive a certain margin recipe from their work, first a
clinical decision on desired CTV coverage probability has to be made. The margin recipe
used in this thesis is for the case that at least 90% of the patients shall get a minimum of
95% of the prescribed dose in the whole CTV. Another fixed input parameter is the width
of the beam penumbra, which has to be regarded in the random error term as σp. This σp
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is estimated with 3.2mm (van Herk et al., 2000) in water equivalent soft tissue, but has to
be larger for lower tissue densities (Witte et al., 2004), resulting in a smaller margin. In
this thesis margins are only calculated for prostate treatments, hence the value for water
equivalent tissue is used, σp is already integrated in eq. (2.1).
The formula to derive a CTV-to-PTV margin M is then:
M = 2.5 · Σ + 0.7 · σ. (2.1)
In this equation Σ and σ represent the standard deviations of the systematic and the random
error in patient position, respectively. These values have to be determined from the patient
population. They are specific for the tumor site, the immobilization method and in principle
for the patient population. They are determined as follows: After collection of data from
various patients, for each patient a mean mP and standard deviation σP of the target’s
deviation from the planned position is calculated. The standard deviation of the systematic
error Σ is then determined as the standard deviation of all patient’s mP . The standard
deviation of the random error σ is calculated as the root mean square of the patient’s σP .
For consideration of different sources of error, like positioning and intrafraction motion,
the standard deviations can be added quadratically, before the margin calculation. All
margins derived in this thesis are isotropic margins, which means that no different margins
for lateral, longitudinal and vertical expansion of the CTV are calculated. Therefore, the
standard deviations are determined in all directions and then added quadratically to three-
dimensional values.
To reduce CTV-to-PTV margins in lung radiotherapy, the treatment planning can be per-
formed with a CT data set representing the time averaged situation, reducing the systematic
setup error. This idea is based on the results from (Engelsman et al., 2001) and (Witte et al.,
2004). This CT data set can be achieved by choosing the best fitting CT from the 4D data
set, then called ‘mid-ventilation CT’ (Wolthaus et al., 2006), or by reconstruction from
a complete 4D CT data set using deformable registration, then called ‘mid-position CT’
(Wolthaus et al., 2008).
2.2.3.3 Probabilistic planning
In probabilistic planning the commonly used static patient model is replaced by a probabil-
ity distributions of patient positions as proposed e.g. by (Löf et al., 1995; Li and Xing, 2000;
Birkner et al., 2003). An implementation of probabilistic planning within a treatment plan-
ning program was realized by (Unkelbach and Oelfke, 2004) by integration of distributions
representing interfraction motion measured with repeated CT scans. The implementation
addresses the two main challenges of probabilistic planning. First, the probability distri-
bution of patient positions is generally unknown and has to be estimated from only a few
snap shots of patient positions. Second, the treatment is performed in a finite number of
fractions. The optimized parameter is the expectation value of the dose, instead of the
static dose value. It was found, that an additional minimization of the dose variance is
necessary to gain clinical applicable treatment plans. This method was further developed
to integrate combined patient specific positioning data and population based knowledge on
position distributions (Unkelbach and Oelfke, 2005).
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Probabilistic planning has also been demonstrated to be able to incorporate variations of
intrafractional breathing motion into a 4D treatment planning process. The classical non-
probabilistic 4D planning approach for consideration of lung tumor motion as e.g. proposed
by (Zhang et al., 2004) uses the different phases of a 4D CT to calculate a motion vector
for each pixel of tissue relative to the exhale phase. This information is used to calculate
cumulative pixel doses summing up all contributions of each breathing phase weighted with
the proportion of breathing cycle time in which this phase is present. This cumulative dose
is optimized instead of a static dose using one CT data set only. This approach does not
consider possible variations in breathing motion over single fractions or the whole treatment
course, the information gathered from the 4D CT is assumed to represent each breathing
cycle during the therapy. To overcome this assumption, probabilistic planning can be used
to regard variations in tumor amplitude and motion baseline in 4D planning, see (Heath
et al., 2009).
2.2.3.4 Repositioning, gating and tracking
In contrast to the motion management methods described previously, the techniques intro-
duced in the following need monitoring of intrafraction motion of the individual patient. In
principle, all near real-time motion detection methods can be used for these methods. The
most simple one is a threshold based repositioning of the patient for non-periodic tumor
motion. For example a new patient alignment procedure is triggered, when a 3mm distance
from planned position for any direction lasts more than 30 s for prostate patients (Curtis
et al., 2013). Another method which is mainly designed for tumors, following respiratory
motion is called gating. The goal of gating is the irradiation only at that points in time,
when the target volume is in a previously defined window of positions. Typically this win-
dow covers the target positions around exhale position (Moorrees and Bezak, 2012), because
of the large proportion of breathing cycle time, which is spent near exhale position and the
better reproducibility of the exhale position in comparison to inhale position.
The most complex method of compensating intrafractional motion is called tracking. The
aim of this technique is a stable relationship between treatment beam and tumor. This can
be achieved by either moving the patient or the beam according to the current detected
patient motion. Approaches for that are as follows: I) a linear accelerator mounted on a
robotic arm (Cyber Knife, Accuray Inc., Sunnyvale, CA), II) a treatment couch mounted on
a robotic arm (Hexapod, Medical Intelligence, Germany), III) tracking of the tumor motion
due to reshaping of the MLC beam aperture for classic gantry based linear accelerators
(Keall et al., 2006, 2014; Krauss et al., 2011b), IV) tracking of the tumor motion by tilting
and panning the accelerator-MLC combination (Vero SBRT, cooperation between Brainlab
AG, Feldkirchen, Germany and Mitsubishi Heavy Industries Ltd., Tokyo, Japan).
From all of these methods, tracking techniques have to deal most with system latency, i.e.
the time between detection of motion and possible reaction on it, due to that, motion has
to be predicted from previous positions. An analysis of different prediction algorithms can
be found in (Krauss et al., 2011a).
20
3 The role of organ motion in prostate
radiation therapy
In this chapter, first, the measured intrafraction prostate motion is quantified. Second, this
data is used to calculate safety margins for different treatment scenarios. And third, the
dosimetric consequences of this motion are determined for 21 patients after an experimental
validation of the 4D dose reconstruction method.
Parts of the following investigations were presented at scientific conferences (Schmitt et al.,
2010a,b, 2012a,b).
3.1 Clinical background and purpose
Prostate cancer is the most common cancer in men in Germany accounting for 25.7% of
all newly diagnosed cancers. This led to about 63500 men with this diagnosis in 2008.
Although the relative 5-year survival rate is the second highest for all cancers, at 92%,
roughly 12000 men died due to prostate cancer in Germany in 2008, ranking it third in
cancer caused mortality. The mean age at diagnosis is 70 years. Looking at time resolved
analysis, the new cases per year are increasing, mainly because of the implementation of
screening. Screening leads to a diagnosis at younger age and at earlier stages of cancer
progression, not causing any clinical symptoms. This leads to a slight decrease in mortality
rate by an increasing incidence rate, because early detected carcinomas are more likely to
be cured. (RKI, 2012)
Beside additional hormone therapy for high risk cases, the two main therapy options for
localized prostate carcinomas are radiotherapy and surgery (radical prostatectomy). The
radiotherapy can be performed as external beam radiotherapy (EBRT) or brachytherapy
(permanent or temporary incorporation of encapsulated radioactive material into the tu-
mor) or as a combination of both. There is no clear advantage of one of the two options
radiotherapy and surgery, neither regarding the overall survival rates nor the spectrum of
side effects. (S3-Leitlinie, 2011; Resnick et al., 2013)
In radiotherapy of localized prostate carcinomas, dose escalation is shown to improve the
clinical outcome (Dearnaley et al., 2005; Peeters et al., 2006). Because of the necessity of
dose sparing for organs at risk, dose gradients and general target volume conformity of dose
distributions have to be optimized for these higher target doses. Therefore, conventional
IMRT and volumetric arc therapy is widely used for prostate patients.
These techniques require advanced assessment and management of interfractional anatomy
changes, patient positioning and intrafractional organ motion. For the selection of proper
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strategies per tumor site or even per patient it is important to know, how large these
deviations are and which dosimetric effects have to be expected.
Intrafractional prostate motion was investigated using for example MV portal imaging (Ned-
erveen et al., 2002; Kotte et al., 2007) or electromagnetic transponders (Kupelian et al., 2007;
Langen et al., 2008b; Shah et al., 2011a). This chapter, first, describes typical motion pat-
terns and quantifies the overall motion amount resulting from the individual motion patterns
of our patients. This investigation characterizes the input for further margin determinations
and calculations of dosimetric consequences of this motion. Due to that, it is presented to
give an overview of the general and time dependent behavior of prostate displacement and is
compared to published motion data to enable a more valuable discussion of the investigations
based on this data presented in the following.
Most investigations on margins for intrafractional prostate motion published so far are based
on complete fractions of conventional IMRT, e.g. (Litzenberg et al., 2006; Tanyi et al., 2010).
Data on intrafraction motion and margins compensating for them considering different frac-
tion times are very rare (Li et al., 2013). For prostate radiotherapy different treatment
techniques and fractionation schemes, leading to different fraction times are applied. Re-
ported treatment times reach from 2min for single arc volumetric-modulated therapy (Chow
and Jiang, 2013) up to 20min to 40min including imaging for hypofractionated linac-based
stereotactic body radiotherapy (Madsen et al., 2007). Therefore CTV-to-PTV margins,
which are necessary to avoid an underdosage of the CTV when no other motion manage-
ment is applied, depending on different treatment times are calculated in this chapter.
In addition, two widely used strategies of MV CBCT usage for prostate patient positioning
prior to each fraction are analyzed in comparison with a positioning using the electromag-
netic system, which serves as ground truth. In these methods, the daily MV CBCT is
compared with the planning kV CT, a translation vector is calculated and the patient is
repositioned according to this vector. A registration of prostate positions in the image data
is not possible, because of the less soft tissue contrast of the MV CBCT compared to the
kV CT. Due to that, it is common either to use the bony anatomy for image registration
or implanted fiducial markers in the prostate. The aim of marker implantation is thereby
the assumption of a better representation of the prostate position, compared to the bones.
Differences in bone and marker positioning are reported for different MV and kV imaging
modalities (Nederveen et al., 2003; Beltran et al., 2008; Tanyi et al., 2010). These differences
are caused by changes of the prostate position relative to the bones from day to day and on
short time scales.
Margins are based on a concept of average motion of a patient population. The motion of
the patient, for which the concept is applied during treatment planning is not considered.
Because of that, this margin is larger than necessary for some patients and smaller than
required for other patients. To quantify this effect, a patient specific evaluation of the
dosimetric consequences of the intrafraction motion is performed. For this, three calculation
methods for dose distributions considering intrafraction motion are evaluated using film
dosimetry in a moving phantom as ground truth. For these film measurements, original
patient motion data of whole treatment courses containing 35 fractions are mimicked by a
movable phantom fixture during the irradiation of all fractions on one film. Based on this
analysis one dose recalculation method is chosen for application to all patient data.
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The dosimetric effects for whole treatment courses reported so far were mainly indicating
to be negligible even on the PTV, although the effect for single fractions was remarkable in
some cases (Li et al., 2008a; Langen et al., 2012). Using the same motion data for calculation
of dosimetric effects for seven field step-and-shoot IMRT (Langen et al., 2012) and helical
TomoTherapy treatments (Langen et al., 2008a), both without a boost concept, very differ-
ent results are obtained. Additionally, several investigations on correlation between motion
amount and dosimetric effect using different motion metrices and dosimetric endpoints are
done concluding that there was a rather poor correlation between the two, (Langen et al.,
2008a, 2012). In this thesis a retrospective quantification of the dosimetric effect of in-
trafraction prostate motion and a correlation analysis between three dosimetric endpoints
of single fraction and cumulative plans and the geometric mean of the prostate displace-
ment is performed for prostate treatments with an integrated boost irradiation delivered by
a conventionally fractionated nine field step-and-shoot IMRT.
3.2 Material and methods
3.2.1 Patient data
All data from prostate patients used in this analysis are collected during a clinical trial
performed in a cooperation between the dkfz and the University Clinic Heidelberg, rep-
resented by the departments of radiation oncology and urology. The title of this trial is
„Online-Erfassung der Prostata-Position und eventueller Repositionierung bei der intensi-
tätsmodulierten bildgestützten Strahlentherapie (IGRT) der Prostata mittels implantierter
Radiotransmitter“ (engl. “On-line detection of prostate position and potential repositioning
for intensity modulated image guided radiotherapy (IGRT) of the prostate due to implanted
radio frequency transmitters”). This trial was approved by the ethics committee of the med-
ical faculty of the University of Heidelberg (approval number MV-086/2007). The patient
selection and information was done in the radiation oncology department. After each pa-
tient had agreed to take part in this trial, three Calypso transponders, as introduced in
section 2.2.2.2, were implanted in the prostate endorectally with ultra sound guidance at
the urology department. The treatment planning and the treatment itself were performed
at dkfz.
One week after the implantation of the transponders, the treatment planning CT was ac-
quired. In this kV CT the transponders were identified and target delineation, dose pre-
scription, calculation and optimization was performed. The general concept of irradiation
was an integrated boost, which leads to a high dose region in the CTV (called a boost
volume) and a lower prescribed dose in the margin around it. The prostate was defined as
boost volume and planned with a prescribed median dose of 76Gy with an enclosing 95%
isodose. This volume was expanded by a margin of 7mm including the base of the seminal
vesicles with a prescribed dose of 70Gy with an enclosing 95% isodose. The larger volume is
called PTV. All used treatment plans were approved and employed for patient treatments,
hence some plans differ from this concept, especially in the posterior margin close to the
rectum, due to the physicians decisions. There was no dietary protocol, but the patients
were asked for having an empty rectum and a full bladder during planning CT and treat-
ment fractions. For each patient, a step-and-shoot IMRT with 9 coplanar equidistant beam
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angles was performed. This treatment was split up in 35 daily fractions. Prior to each frac-
tion an MV CBCT was acquired for image guided patient position correction. After that,
the Calypso System was used to determine the prostate misalignment. Depending on the
detected positioning errors by both systems, the patient was repositioned either using the
Calypso information or the MVCT information depending on the physician’s decision. After
the completion of the positioning procedure, the irradiation was performed with concurrent
prostate motion monitoring with the Calypso System.
For 25 enrolled patients the intrafractional prostate motion was monitored. For each in-
vestigation presented in this thesis, specific requirements had to be fulfilled e.g. regarding
number of fractions with complete Calypso data set or length of data sets. Therefore for
each investigation a different subset from these 25 patients was chosen.
Depending on the analysis, the following patient related data was used: I) kV planning CT,
II) treatment plan including all beam angles, beam apertures and applied monitor units
per segment, III) daily MV CBCT data sets and IV) Calypso motion data including beam
status report.
3.2.2 4D dose reconstruction methods
This section describes the methods used to reconstruct dose distributions applied to a moving
phantom or patient. In a first part, the dose calculation itself, based on the interaction of
the applied radiation with the matter of the phantom or patient, is depicted. Using these
methods, the dose distributions are optimized during the treatment planning process under
static conditions. Second, it is presented how dose distributions are accumulated considering
the phantom or patient motion during irradiation.
3.2.2.1 Dose calculation models
Dose calculation in radiation therapy is usually divided in two parts. (1) The determi-
nation of the output of the radiation source and (2) modeling of the interaction between
the radiation and the patient leading to the absorbed dose in the patient. The output of
the radiation device, here the properties of the primary photon beam, is determined once.
This determination is independent of the dose calculation algorithm used to compute the
dose deposition in the patient, in principle, but the needed input parameters vary between
algorithms.
The primary photon beam The best estimation of the output phase space of the accel-
erator would be determined with a complete Monte Carlo simulation beginning with the
electron spectrum emitted by the electron gun, tracing the electrons to the bremsstrah-
lungstarget and then simulating the interactions of the produced photons until the beam
aperture forming devices, specific for the patient. In this way, data on the distribution of
photon energies and directions as well as the fluence, i.e. the number of photons crossing
a specified area, can be derived directly. Additionally, this simulation will provide infor-
mation about electrons contaminating the primary photon beam. But such a Monte Carlo
simulation requires exact knowledge of all involved components, which is often not available
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in clinical practice. To overcome this lack of information, measurements have to be per-
formed for example to determine depth dose curves, lateral dose profiles and the influence
of the aperture forming collimators due to beam scattering. This measured data is then
fitted to simulated data to establish a beam model. For example, the depth dose curve can
be compared with depth dose curves for a weighted sum of mono energetic photon beams,
generated with Monte Carlo simulations, the contaminating electrons are thereby implicitly
accounted for by an over weighting of low photon energies. In this way, a model of the
primary photon beam, that is compatible with the measured data, can be determined. If
the dose calculation in the patient is performed with Monte Carlo simulations, too, the
modeled phase space can be used as input directly (for an overview of beam modeling issues
in Monte Carlo methods in radiation therapy, see (Chetty et al., 2007)). For kernel based
dose calculation algorithms the primary energy fluence of the photon beam can be derived
from the measurements and used as input. The primary energy fluence ψ describes the
energy of the radiation field per area in each point in space r for each contributing photon
energy E and its corresponding primary fluence φ:
ψ(E, r) = E · φ(E, r). (3.1)
Primary thereby denotes the aspect, that these photons are produced outside the patient,
in contrast to secondary electrons or Compton photons inside the patient. From now on,
energy or particle fluence always refers to the corresponding primary fluence.
Dose deposition in the patient The calculation of the applied dose to the patient in
clinical practice shows two conflicting requirements. First, the result should be as accurate as
possible, but second, the calculation has to be as fast as possible. Speed of dose calculation is
important during the iterative treatment plan optimization process, requiring a large number
of calculations, in particular. The final dose calculation using the optimized beam apertures
and beam weights for evaluation of the dose distribution can be performed with a more
accurate slower algorithm, in principle. The most accurate method of dose calculation in
the patient is a Monte Carlo simulation for which the material composition of the patient is
estimated from the patient CT, an introduction to Monte Carlo treatment planning methods
can be found in (Fippel, 2006). This simulation is much more time consuming than other
methods, but recent developments in simulation software as well as in the used hardware
made it clinically available in some commercial treatment planning programs (Monaco by
Elekta AB, Stockholm, Sweden, MultiPlan by Accuray Inc., Sunnyvale, CA, US, ViewRay
treatment planning system by ViewRay Inc., Cleveland, OH, US).
Nevertheless, the classic approach of dose calculation, a kernel based method introduced
by (Mackie et al., 1985) and (Ahnesjö et al., 1987), is used in the vast majority of clinical
dose calculations and is applied to all patient cases considered in this thesis. Kernel based
methods divide the dose deposition in two components. First, the energy transferred to
the patient by primary interactions of the photon beam with the patient is determined
and second, the dose deposition around each point of primary photon interaction, done by
secondary electrons, is modeled by a so called dose kernel. The inaccuracy inherent in the
kernel methods is the assumption of a patient consisting of water, while the different media
like bone and diverse organ tissues are considered as water with different electron densities
in an inhomogeneity correction. This assumption leads to deviations between the calculated
25
Chapter 3. The role of organ motion in prostate radiation therapy
(a) (b)
Figure 3.1: Calculated dose distributions for a pencil beam algorithm (a) and a Monte Carlo
simulation (b) in a lung case, the scale is in Gy. The optimization was performed with pen-
cil beam dose distributions. The Monte Carlo recalculation of the delivered dose shows an
underdosage of approximately 20% in the tumor. Taken from (Siggel, 2012), with permission.
dose using kernel based methods and Monte Carlo calculations, often used as gold standard.
The amount of these deviations depends on the applied kernel method and on the presence
and distribution of not water equivalent tissues. Largest effects are observed in the head
and neck region and in lung irradiation, because of a high percentage of air filled cavities
and lung tissue with very low density. An example of deviations between dose calculation
with a pencil beam kernel and with a Monte Carlo algorithm in a lung case is shown in
fig. 3.1.
In the following, the principle of dose calculation with point spread and pencil beam kernels
will be explained for dose deposition in water, after that, the inhomogeneity corrections are
presented. The energy transfer from the photon beam to the patient is thereby described
by the TERMA T (Total Energy Released per unit MAss). The TERMA for each photon
energy E and point in space r is given by the linear attenuation coefficient µ, the mass
density ρ and the energy fluence ψ:
T (E, r) = µ(E, r)
ρ(r) · ψ(E, r). (3.2)
Depending on the specific photon energy the attenuation coefficients for the photoelectric
effect, the Compton effect and pair production has to be considered. The spatial dependence
of the energy fluence can be described approximately by the attenuation of the photon
fluence φ due to the traversed medium until the regarded point r. The photon fluence φ(d)
in the tissue depth d is attenuated to:
φ(d) = φ(0) · e−µ·d, (3.3)
with the initial fluence φ(0). The deposited dose D in the patient for each point r is the
result of the superposition of the dose contributions from each primary interaction point r′.
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This dose contribution can be calculated via a multiplication of the TERMA T (r′) in the
primary interaction point and the dose kernel k(r, r′) describing the energy transport from
r′ to r. An integration over all primary interaction points and all occurring photon energies
E′ gives the dose D(r):
D(r) =
∫
E
∫
V
T (E′, r′) · k(r, r′, E′) dr′dE′. (3.4)
These kernels k are called point spread functions or point kernels and the corresponding
calculation is called a superposition algorithm. Kernels for each photon energy can be
derived with Monte Carlo simulations or by adapting analytical models using measured data.
With the assumption of a translational invariant kernel, the calculation can be transformed
to a convolution algorithm, which can be performed much faster:
D(r) =
∫
E
∫
V
T (E′, r′) · k(r − r′, E′) dr′dE′ =
∫
E
(T ∗ k)(E′, r) dE′. (3.5)
To further reduce the computational effort, the concept of a pencil beam kernel can be
used, as proposed e.g. by (Mohan et al., 1986) and (Ahnesjö et al., 1992). The idea is to not
account for every single primary photon interaction during the dose calculation but to use
pre-calculated kernels describing the dose deposition of an infinitely narrow photon beam
(pencil beam). This pencil beam kernel kPB is achieved by integrating point dose kernels
for primary interaction points over depth in water. A schematic of a point dose kernel
and a pencil beam kernel is shown in fig. 3.2. These pencil beam kernels are explicitly
dependent on the water depth d and account for the whole energy spectrum in this depth
and the attenuation of the primary photon beam. Hence, the dose calculation for each
point D(x, y, d) with x and y being the coordinates perpendicular to the incident photon
beam is reduced to a two-dimensional convolution of the energy fluence ψ(x, y) for the whole
spectrum and the pencil beam kernel:
D(x, y, d) =
∫
x
∫
y
ψ(x′, y′) · kPB(x− x′, y − y′, d) dx′dy′. (3.6)
The assumption of a translational invariant polyenergetic kernel neglects the lateral differ-
ences in beam spectrum, called off-axis beam softening. It has been shown, that the use of
the energy fluence ψ(x, y, d = dref) in the reference depth dref = 10 cm water instead of the
common use of the incident energy fluence ψ(x, y, d = 0) can compensate for that (Ahnesjö
and Trepp, 1991).
The kernel based algorithms described so far are based on dose deposition in water and do
not account for tissue inhomogeneities. The integration of inhomogeneity corrections differs
from method to method and thereby leads to an increasing inaccuracy with an increasing
level of approximation from superposition to pencil beam algorithms. All these corrections
use the concept of a radiological depth, which is illustrated for a medium containing 3 tissues
with different relative electron densities ρe compared to water in fig. 3.3. The radiological
depth dr has to be calculated as weighted sum over the tissues until the considered depth:
dr =
N∑
i=1
ρe(i) · di, (3.7)
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point of photon
interaction
water
Figure 3.2: Dose kernels describing the energy deposition around primary photon interaction
points in water. For the point kernel (left) only one interaction point is regarded, while the pencil
beam kernel (right) accounts for all interaction points of a narrow photon beam. Adapted from
(Siggel, 2008), with permission.
with N crossed tissue sections and their relative electron densities and path length, as
depicted in fig. 3.3. The path lengths are thereby determined using a so-called ray tracing
algorithm.
Most obvious, this radiological depth can be used instead of the geometrical depth d to
determine the fluence in eq. (3.3). In a second step, the dose kernels have to be adapted
to the specific spatial tissue distribution. This adaption is based on O’Connor’s theorem,
which indicates, that for an impinging energy fluence the deposited dose in a volume v1 with
electron density ρe,1 equals the dose in a volume v2 = (ρe,1/ρe,2)3·v1 with the electron density
ρe,2, (O’Connor, 1957). For point kernels a ray tracing between each primary interaction
point r′ and each dose point r can be performed to calculate the respective radiological
depth and derive a irregular shaped dose kernels. During this ray tracing a linear path of
the secondary electrons is assumed, which is less accurate for growing distances between
r′ and r. The isodose lines of these kernels will be stretched/compressed compared to the
water kernel when a tissue with a lower/higher electron density compared to water has to
be traversed. These adapted point kernels are not translational invariant and can thereby
be used only for superposition methods and not in a conventional convolution algorithm.
When the concept of radiological depth is applied to correct pencil beam kernels for tissue
inhomogeneities, the kernels are simply stretched or compressed regarding traversed tissue.
This is done by substitution of the geometrical depth d with the radiological depth dr in
eq. (3.6). Because of the narrow beam geometry, no lateral deviations are considered. This
leads to the assumption of a local slab geometry of different tissues.
Regarding the different levels of approximation and the quality of inhomogeneity corrections
the dose calculation algorithm should be chosen depending on the treatment site. In the
aforementioned head and neck region and for lung irradiations a superposition or Monte
Carlo based algorithm should be used. Other anatomical regions are sufficiently homogenous
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e,1
e,3
e,2
Figure 3.3: Schematic for the determination of the radiological depth from point S to point P .
For each region of electron density the path length has to be determined. Adapted from (Siggel,
2008), with permission.
by means of electron density to justify the use of a pencil beam algorithm for fast dose
calculation. Because of that, the dose distributions calculated for prostate patients in this
thesis are generated with a pencil beam algorithm in an in-house implementation following
(Bortfeld et al., 1993).
3.2.2.2 4D dose accumulation
The retrospective analysis of dosimetric consequences of intrafraction organ motion implies
an accumulation of delivered dose in each analyzed voxel of the patient or phantom CT.
For this accumulation two different concepts are used in this thesis. In the first one the pre-
calculated static dose distributions serve as input for a convolution with a possibility density
function of the occurring target displacements, while in the second concept a new dose
calculation within the treatment planning program is performed using motion dependent
target points.
Dose accumulation by convolution For each voxel of interest in the static patient CT, the
dose contribution of each part of the patient motion has to be considered. When possible
interplay effects between patient motion and accelerator head and collimator leaf motion is
neglected, this can be done by a convolution of the static dose distribution Dstatic with a
probability density function p of the target displacement, see eq. (3.8). The ‘moved’ dose
distribution Dmoved(r) in each CT voxel is thereby estimated as integral over the dose in
all voxels r − r′ of the static dose distribution, weighted with the probability p(r′) of this
specific displacement during the irradiation.
Dmoved(r) = (Dstatic ∗ p)(r) =
∫
Dstatic(r − r′) · p(r′)dr′. (3.8)
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Figure 3.4: Example of Calypso motion data for one fraction. Shaded areas indicate times of
irradiation (IMRT segments).
We made this calculation with two types of motion data sets acquired with the Calypso
System. In the first case, all collected data points between the first and the last Calypso
beam-on signal of all fractions were filled in one pdf of prostate displacements, later ad-
dressed as ‘whole dataset convolution’. In the second case, only the motion data with acti-
vated Calypso beam-on signal was used for the pdf, this means the motion during pauses
between the beams and segments was ignored, this method is later addressed as ‘beam-on
convolution’. This was done to evaluate, if there are characteristics of intrafraction prostate
motion depending on the beam status, recognized by the patient, which are dosimetrically
relevant. A pattern of beam-on and beam-off phases can be seen in fig. 3.4.
All convolutions were done using a MatLab script (The MathWorks Inc., Natick, MA).
Plan recalculation with shifted target points To consider all interplay effects in the dose
accumulation, a method to recalculate dose distributions for given treatment plans and
target motion data was implemented for our in-house treatment planning system. This
tool performs a dose calculation for each delivered IMRT segment using a dedicated target
point, determined from the motion data, to simulate the process of irradiation. Each of
the 35 fractions were delivered in about N ≈ 80 IMRT segments. For all segments, the
mean prostate misplacement was determined from the Calypso data and converted to our
CT coordinate system, denoted with (x, y, z). The relation to the IEC-61217 axes (Calypso
System) here denoted as ‘lat, long, vert’ is as follows: x = lat, y = -vert and z = long.
Using these misplacements, dose distributions were calculated based on the static treatment
plans with the following procedure. For every segment s of every fraction f the dose distri-
bution df,s(r, x, y, z) with r being a point in space and x, y, z the current target point was
calculated. The current target point is defined as (x, y, z) = (x0 − x¯f,s, y0 − y¯f,s, z0 − z¯f,s)
with the original static target point (x0, y0, z0) and the lateral, longitudinal and vertical seg-
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ment’s mean prostate misplacement (x¯f,s, y¯f,s, z¯f,s). The resulting dose distributions were
then summed up to 35 ‘moved’ fraction plans and one ‘moved’ cumulative plan for every
patient, see eqs. (3.9a) and (3.9b).
Dmoved,f (r) =
N∑
s=1
df,s(r, x, y, z), (3.9a)
Dmoved, cum(r) =
35∑
f=1
Dmoved,f (r). (3.9b)
3.2.3 Dose reconstruction – validation strategies
To validate the 4D dose accumulation methods, film measurements were performed as
ground truth. In this section, the experimental setup is described as well as the used
concepts to compare dose distributions.
3.2.3.1 Experimental setup
Dose distributions in a static and in a moving phantom were measured with the setup shown
in fig. 3.5(a). The films were placed in the isocentric transversal slice of a cylindrical solid
water phantom with a diameter of 20 cm, which can be seen in fig. 3.5(b). The phantom
was mounted on a platform which can mimic 3D motion.
As described later, in section 3.2.4.2, treatment plans and motion data of four patients were
chosen for the experimental validation. For each case two film measurements were per-
formed, a static and a moved one. First, one static fraction was irradiated on a radiographic
Kodak EDR2 film (Carestream Health Inc., Rochester, NY). Second, 35 fractions were irra-
diated on one radiochromic MD-V2-55 film (International Specialty Products, Wayne, NJ)
while the phantom was moving accordingly to the Calypso motion data. In this way a cu-
mulative ‘moved’ dose distribution of the whole treatment course was produced on the film.
One of these irradiated MD-V2-55 films is shown in fig. 3.5(c).
The EDR2 films were developed and then all films were scanned with a Dosimetry Pro
Advantage Vidar scanner (Vidar systems cooperation, Herndon, VA) with a resolution of
300 dpi. Film calibration was made using measurements up to 2.9Gy for the EDR2 films
and up to 118Gy for the MD-V2-55 films.
3.2.3.2 Quantification of dosimetric differences
The validation of calculation methods as well as the evaluation of dosimetric consequences
of the intrafractional motion is based on a comparison of dose distributions. Either between
measured and calculated dose distributions or between different calculations. For these
comparisons a γ-index analysis is used for both investigations, while the change in D95% of
patient specific target volumes is used in the patient application part only.
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(a)
(b) (c)
Figure 3.5: Experimental setup of the film measurements consisting of the Siemens Artiste
treatment device and the programmable phantom fixture with the mounted phantom (a). De-
tailed view on the phantom made of circular solid water plates. The film is placed in the central
plate gap (b). Radiochromic MD-V2-55 film after irradiation of 35 fractions in the moving
phantom. The marked laser positions can be seen as black dots (c).
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γ-index analysis The γ-index concept (Low et al., 1998) is a combination of pure dose
differences and spatial dose deviations. It is based on a pixel-by-pixel comparison and can
be performed either in 2D or 3D. All pixels re in the evaluated dose distribution for which
a pixel rr in the reference dose distribution exists, giving a Γ(rr, re) ≤ 1 in eq. (3.10), pass
the criterion, defined by a dose difference ∆D and a spatial distance ∆d, either defined in
2D or 3D. The γ-index is the percentage of pixels in the evaluated dose distribution passing
the Γ criterion.
Γ(rr, re) =
√
|re − rr|2
(∆d)2 +
(De(re)−Dr(rr))2
(∆D)2 . (3.10)
We used a 3 %/3 mm γ-index in most cases. This means the result is the percentage of
pixels in the evaluated dose distribution for which there is a pixel in the reference dose
distribution with the same dose in a 3mm neighborhood or a 3% deviating dose in the
pixel at the same place and combinations between these cases. There are two possibilities to
define the dose difference leading to a ‘global’ or a ‘local’ γ-analysis. For the global analysis,
the dose difference is defined related to the maximum dose and for the local analysis, it is
defined relative to the dose in the evaluated pixel. The γ-evaluations made in this thesis
are local γ-evaluations, to account for dose deviations outside the high dose region, too.
Change in D95% of a target volume It is also common to compare clinical dose distribu-
tions based on the dose calculated for a patient specific target volume like the CTV or the
PTV. For this purpose, the D95% of the considered volumes is calculated and compared.
The D95% is defined by the constraint that 95% of the considered voxels receive a dose
higher than D95%.
3.2.4 Performed investigations and procedures
3.2.4.1 Quantification of prostate motion and its impact on margin sizes
Motion characteristics and quantification First, a visual classification of the collected
motion data yields a qualitative overview of the occurring motion patterns. Second, a
quantitative analysis of the time dependent overall motion amount resulting from these
motion patterns was done using all recorded intrafraction motion data.
Intrafraction prostate motion was summarized for all patients. Resulting in a population
based non-individual analysis of motion amount in all three directions and in 3D. Data from
844 treatment fractions from 25 patients was used. For each data set, the points in time
between the beginning of the first beam and the end of the last beam, as measured and
recorded by the Calypso System, were employed. To consider intrafraction motion only,
possible deviations from the planned position were set to zero at the time the first beam
starts.
For each point in time after start of irradiation the mean and standard deviation for lateral,
longitudinal and vertical prostate deviation from planned position was calculated. Addition-
ally the three-dimensional distance between actual and planned position was determined.
33
Chapter 3. The role of organ motion in prostate radiation therapy
 0
 0.1
 0.2
 0.3
 0.4
 0.5
−4 −2  0  2  4
F r
a c
t i o
n  
o f
 d
a t
a
Prostate displacement [mm]
lat
1 min
5 min
9 min
−4 −2  0  2  4
Prostate displacement [mm]
long
−4 −2  0  2  4
0
0.1
0.2
0.3
0.4
0.5
Prostate displacement [mm]
vert
Figure 3.6: Histogram of the distribution of lateral, longitudinal and vertical prostate position
for 15 patients. In each diagram data for 1, 5 and 9min of treatment is displayed.
The time dependent behavior of these parameters was analyzed. It was also calculated for
which part of time the 3D prostate displacement exceeded specific deviation thresholds per
fraction and for all collected motion data.
Margins for different treatment times In this analysis only patients were included, whose
recorded intrafraction motion data between start of first beam and end of last beam lasts
for at least 9min for all fractions. This leads to 340 analyzed fractions for the 10 patients
in (Schmitt et al., 2010b), in the following the study is extended by data from another 5
patients giving 507 fractions in sum.
From the 9min lasting data sets margins for daily treatment times ranging from 1min to
9min were deduced. All calculations, except the margin determination itself, are made
separate for the three motion directions, for simplicity, the following equations are given for
the x-coordinate, only. As can be seen in fig. 3.6, the motion amount per minute is increasing
with enhanced treatment times. As the aim was to determine margins for different lengths
of treatment time, without any bias due to this fact, each evaluated motion pattern starts
at the beginning of the first beam ts for each fraction f . This leads to the same number
of data sets for all simulated treatment times. To consider intrafraction motion only, all
intrafractional prostate positions xp,fintra, t at time t are taken relative to the start position for
patient p and fraction f :
xp,fintra, t = x
p,f
t − xp,ft=ts , (3.11)
with the original detected prostate position xp,ft . The data sets resulting from these pro-
cedures are combined per patient and treatment time. For each patient and treatment
duration d = 1 . . . 9 min a data set was constructed by stringing together all fractions F .
Each fraction data consists of d · 600 data points, because of the 10Hz update frequency.
34
3.2. Material and methods
This lead to nine combined data sets per patient, one for each treatment duration. For
each fraction time, the mean md,p of the prostate displacement was calculated from these
combined data sets for each patient:
md,p =
F∑
f=1
d∑
t=ts
xp,fintra, t
F · d · 600 , (3.12)
together with the corresponding standard deviation σd,p. As described in section 2.2.3.2,
population based isotropic CTV-to-PTV marginsMd were derived from this patient specific
data using the recipe of (van Herk et al., 2000) via the standard deviations of the systematic
error Σd and the random error σd, calculated for d = 1 . . . 9 min.
Margins for IGRT positioning strategies The margins calculated so far consider intrafrac-
tion motion only. Thus a perfect patient positioning procedure is assumed. To estimate the
needed margin for consideration of patient setup and intrafractional motion in combination,
in the following two methods of image guided patient positioning in prostate radiotherapy
using MV cone beam CT are quantitatively evaluated. It is analyzed, which margins should
be used to account for positioning errors, if these methods are applied. The Calypso local-
ization serves as ground truth for the prostate position. Data of 10 patients was used for
this analysis. For each patient the kV planning CT was used together with the MV CBCT
data acquired prior to each treatment fraction. As ground truth served the first position
the Calypso System recorded for patient localization. For these 10 patients data from 289
fractions were found to be suitable for the investigations in terms of completeness.
The kV planning CT, acquired with a Toshiba Aquilion CT scanner (Toshiba Corporation,
Tokyo, Japan) had the following parameters: 512×512 pixel per transversal slice with a pixel
size of 0.976mm and a slice thickness of 2mm. The image reconstruction was performed
with the standard abdominal kernel (FC13). The daily MV cone beam CT was acquired
using the treatment beam of the Siemens Artiste with an opposing flat panel detector, see
section 2.2.2.1. The acquisition parameters for these MVCTs were the following: 10 Monitor
Units, 360◦ rotation, one projection per degree. The image reconstruction was performed
using a smoothing kernel, resulting in a 3D data set with 512 × 512 pixel per slice with a
three-dimensional isotropic edge length of 0.54mm of each voxel.
Three implanted Calypso beacons could be identified in the prostate on all considered MV
CBCTs and the related kVCT data employed for therapy planning. For each MVCT two
image registrations with the planning kVCT of the corresponding patient were made. The
aim of the first registration was an anatomy match, dominated by the bone structures. The
second match was performed to align the transponder positions. For both a different volume
of interest (VOI) was defined in the MVCT. For the first match we used the whole MVCT
data set. For the second registration, the transponder match, we defined a small area with
the transponders in them. For this the transponder positions in the MVCTs were used,
which were read out for ensuring that they do not migrate. For all three directions we used
the highest and lowest value of beacon position coordinates to define the bounding box for
each patient. Then a 5mm margin in all directions was added for read out inaccuracies of
the beacon positions and inclusion of all transponder edges.
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For the image registration an in house implementation of the mutual information match
recommended by (Maes et al., 1997) was used. The chosen registration parameters were a
histogram of 256× 256 bins and 735000 voxels. This means a subsampling for the big VOI
and a supersampling for the small VOI. To shorten the calculation time, for all registrations
a pre-match was performed based on the shift vector between the isocentre in the kVCT and
the zero position of the MVCT. These points would represent the same point in the patient
for perfect patient positioning. For fractions with large deviations between the prostate
position in the MVCT and the planned target position, the pre-match had to be adapted
visually before the beacon match.
We compared the shift vectors from both image registrations with the shift vector the
Calypso System indicates in the beginning, the so called localization of the patient. All
shifts ~t are accompanied with rotations around all three axes (rotation matrix M). Because
of that the shifts are correct only for the rotation point. The rotation point of the image
registrations is the central point of the MVCT data set ~c. The Calypso System gives the
rotation in relation to the planned isocenter ~i, or the beacon centroid ~b, depending on the
Calypso localization mode, see section 2.2.2.2. The shifts of the image registrations were
recalculated in the particular Calypso coordinate system using eq. (3.13), here denoted for
the isocentric localization mode. The index of ~t indicates the coordinate system.
~ti = ~tc − (~i− ~c) +M crot · (~i− ~c). (3.13)
The differences between the shift vectors originating from image registrations and the Ca-
lypso shift vector are then used for margin determination. Thereby, the Calypso data served
as ground truth. The standard deviation of the systematic error Σ and the standard devia-
tion of the random error σ of the differences between shifts determined with image registra-
tions and Calypso shifts are calculated. Isotropic three-dimensional CTV-to-PTV margins
were determined with these input parameters like described in section 2.2.3.2, eq. (2.1).
3.2.4.2 Experimental validation of 4D dose reconstruction
From the 21 patients used for the evaluation of dosimetric consequences of intrafraction
prostate motion, described in section 3.2.4.3, four were chosen for experimental validation
of the accumulated dose using film measurements as ground truth. These are the patients
2, 3, 6 and 7. The criteria of patient selection for evaluation were the number of available
fractions and good representation of the range of the observed motion amount. The film
measurements are described in section 3.2.3.1.
Dose calculation for the phantom The treatment plans of these four patients were trans-
ferred to a CT of the solid water phantom. The static phantom dose for one fraction was
calculated following the common method used for IMRT plan verification at dkfz, described
by (Rhein et al., 2002), aligning the center of the water equivalent material to the machine
isocenter. For each patient plan, three ‘moved’ dose distributions summing up whole treat-
ment courses were calculated using the methods described in section 3.2.2.2 with the original
patient motion data.
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For both convolution methods, the calculation was performed as follows: I) The static
phantom dose was linearly interpolated to a grid size of 0.25× 0.25× 0.25mm3 and scaled
with a factor 35 to a whole treatment course. II) Depending on the type of convolution,
the appropriate motion data of all fractions was filled in one probability density function
(pdf) per patient also binned in 0.25× 0.25× 0.25mm3 intervals. III) The convolution of
static dose distribution and the pdf was performed for all four patients and both convolution
methods.
The dose recalculation using the shifted target point was applied to the phantom CT using
the patient’s treatment plans and mean displacements per IMRT segment. The ‘moved’ dose
distribution was calculated using our tool within the treatment planning software for each
fraction and then summed up to one cumulative dose distribution, see eq. (3.9). After that,
the dose distributions were also linearly interpolated to a grid size of 0.25× 0.25× 0.25mm3.
This small voxel size makes the comparison with the film measurements more reliable.
Comparison of measured and calculated dose For the comparison, the γ-evaluation tool
within the verification software VeriSoft 3.2 (PTW, Freiburg, Germany) was chosen. In this
software, the algorithm proposed by (Depuydt et al., 2002) is used. We chose the calculated
dose distributions as reference matrices for the γ-evaluations, because of the larger pixel size.
Before the irradiation, the phantom was aligned manually to the laser coordinate system in
the treatment room. The lateral and vertical position of the film isocenter was determined
from the marked laser positions. An 8× 8 cm2 region of interest (ROI) around the isocenter
was selected for a 3 %/3 mm local γ-evaluation. The size of this ROI is restricted by the
size of the MD-V2-55 films. All pixels with a dose less than 10% as the maximum reference
dose were ignored during evaluation to avoid influence of very small dose deviations outside
the high dose region. To consider systematic misalignements in longitudinal direction, each
of the films was compared with all transversal plan slices within a distance of 2mm from
the isocenter (17 slices per film) of all corresponding calculated dose distributions and the
best fitting slice for every film was chosen. The specific longitudinal plan coordinate for
each moved film was determined from the target point shifted plans. This did not lead to
an advantage for the method of shifting the target point in the comparison, because of very
small differences both in best fitting plan slice and between γ-indices from slice to slice, see
section 3.3.2.1.
Comparison of calculated dose distributions For the four patients used for the film mea-
surements, a comparison of the calculated dose distributions were made similar to the film
comparisons. For each patient, the comparison was made only for the transversal slice the
moved film is related to. The ROI was extended lateral and vertical to 11× 11 cm2. A
larger ROI could not be evaluated, because outside this area there are small holes in the
phantom plates, which are necessary for marking the laser positions on the films. Under
these conditions γ-evaluations with 1 %/1 mm and 3 %/3 mm criteria were performed.
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Figure 3.7: Frequency distribution of the segments mean three-dimensional prostate displace-
ment over all patients. The total number of used segments is about 60000.
3.2.4.3 Dosimetric consequences on prostate IMRT
21 patients were chosen from the 25 patients trial cohort using the criterion of a minimum
of 32 from 35 delivered fractions completely reported by the Calypso System. For all inves-
tigations needing a full treatment course, missing fractions were substituted by randomly
chosen other fractions of the same patient to accumulate the whole prescribed dose. In total
17 out of 717 fractions were reused. Some fractions have data gaps of a few seconds which
were filled by linear interpolation. To account for the intrafraction motion only, a perfect
patient setup prior to the first beam of every fraction was assumed.
The three-dimensional prostate displacement of every segment used for this evaluation is
shown as frequency distribution in fig. 3.7.
Calculation of ‘moved’ dose distributions For all 21 patients, ‘moved’ fraction dose distri-
butions and one ‘moved’ cumulative dose distribution were calculated for comparison with
the static fraction dose and the static cumulative dose. The ‘moved’ dose distributions were
calculated using the target point shifting method, because of the reasons given in the dis-
cussion of the experimental validation (section 3.4.2.1). For these calculations the original
voxel size of 1.95× 1.95× 2 mm3 was kept.
Comparison of static and ‘moved’ dose distributions For each patient, the corresponding
‘moved’ and static dose distributions for fraction plans and cumulative plans are compared
using a MatLab script (The MathWorks Inc., Natick, MA) implemented following (Low
et al., 1998). This script performs a three-dimensional 3 %/3 mm local γ-evaluation for the
following volume of interest (VOI). In the isocentric transversal slice a 16× 16 cm2 region is
defined with the isocenter in the middle. This mask was then transferred to all other slices
to expand the VOI to the whole longitudinal plan range. The 16× 16 cm2 ROI in each plan
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slice was chosen to be as large as possible without including the treatment couch. The static
plans were used as reference dose distributions in the evaluation. As in the experimental
validation voxels with a static dose less than 10% of the maximum dose were neglected to
eliminate the influence of low dose regions.
For each of the static and ‘moved’ plans per fraction and treatment course, the D95% was
determined for the boost volume and the PTV, like defined in section 3.2.3.2. This was done
using an in-house developed script for dose volume histogram analysis. For all fractions and
cumulative plans, it was calculated how much the D95% differs for both the boost volume
and the PTV between ‘moved’ and static dose distributions.
Correlation between motion amount and dose perturbation To relate the dosimetric
changes with the amount of motion during the particular fraction or treatment course, for
each fraction and hence for each treatment course the three-dimensional mean prostate
displacement was calculated. For these parameters and the three dosimetric endpoints: γ-
index for the comparison of static and ‘moved’ dose and the occurring changes in the D95%
of the boost volume and the PTV, Pearson’s linear correlation coefficient was calculated for
single fractions and for whole treatment courses.
3.3 Results
3.3.1 Quantification of prostate motion and its impact on margin sizes
3.3.1.1 Motion characteristics and quantification
There are two main types of intrafractional prostate motion occurring in our data, which can
be seen in fig. 3.8. This motion mainly takes place in the longitudinal and vertical directions,
while the lateral position of the prostate remains very stable. The two motion patterns are
called spikes and drifts. Spikes are recurring prostate deviations, as can be seen in fig. 3.8(a),
they are probably caused by rectal gas passing the prostate. Additionally the prostate can
drift in negative longitudinal and vertical direction, which is shown in fig. 3.8(b). Which
means for a patient lying in head first, supine position, a drift towards feet and back. Drifts
are mainly associated to consecutive bladder filling and muscle relaxation in the pelvic
region. Both motion patterns can occur concurrently.
The used data sets cover 9.4min on average with a standard deviation of 0.8min. The
length ranges between 5.4 and 16.5min. In fig. 3.9 can be seen how the lateral, longitudinal,
vertical and three-dimensional prostate displacements develop over time. Because of the
different length of recorded fractions, there are only a few motion data available for long
treatment times. Due to that, the first 9min are displayed only, ensuring a minimal content
of 77% of all fractions for each data point.
Analyzing the three motion directions, the following results are obtained. The lateral mean
prostate position is very stable over time, with a maximum deviation of about −0.2mm,
which is recovered to be smaller then −0.1mm in the end. The standard deviation of
lateral prostate position is thereby growing continuously over time to about 1.0mm at
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Figure 3.8: Example of prostate motion recorded by the Calypso System. Typical motion
patterns can be seen: (a) Spikes in the longitudinal and vertical direction and (b) Drift in the
longitudinal and vertical direction.
9min, see fig. 3.9(a). The longitudinal and vertical prostate positions show a continuous
drift towards negative values, resulting in a mean prostate displacement after 9min of −0.9
and −0.8mm in longitudinal and vertical direction, respectively, as shown in figs. 3.9(b)
and 3.9(c). Additionally to these drifts, the standard deviations around the mean values
increase up to 1.9mm for longitudinal position and to 2.0mm for vertical position.
The distribution of 3D prostate deviations is positively skewed, because of an accumulation
of small values with a few outliers towards large deviations and no negative values. This
leads to a large deviation between mean and median of the distribution. Therefore the
median is chosen to represent the data and is shown in fig. 3.9(d). The mean is 0.25mm
larger than the median, for all points in time on average. For the three unidirectional
distributions, this difference is below 0.06mm. Because of the increase of three-dimensional
prostate displacement with time, the mean–median distance is growing as well and reaches
0.6mm for 9min. To illustrate the width of the 3D distribution, instead of the standard
deviation, the range of values, covering 68.3% of all data was calculated. The median
thereby splits the region in two 34.15% covering regions, which are not of the same size.
This illustrates the asymmetry of the distribution. As can be seen in fig. 3.9(d), the median
3D prostate displacement increase up to 2.1mm with a 68.3% range covering 3.1mm for
9min.
For all points in time between start and end of irradiation the 3-dimensional prostate dis-
placement was calculated. With this data, the percentage of time, in which the displacement
is above a specific threshold is determined for each fraction and for the whole data set. In
table 3.1 the results per fraction are shown. For each fraction the percentage of the specific
displacement is calculated. From this data the mean, median and maximum percentage
is determined. For thresholds between 1 and 10mm the mean percentages decreases from
60.9% to 0.2%. Up to a displacement of 3mm the mean and the median are of the same or-
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Figure 3.9: Trend of prostate motion over time for all 844 fractions. For the lateral (a),
longitudinal (b) and vertical (c) direction the mean value for each point in time is shown with
the corresponding standard deviation. For the three-dimensional motion (d) the median value
for each point in time is given with a band of 68.3% of the corresponding data points equivalent
to the SDs.
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Table 3.1: Mean, median and maximum of the percentage of time for which the three-
dimensional prostate displacement exceeds a specified threshold value per treatment fraction.
Displacement [mm] 1 2 3 4 5 6 7 8 9 10
Mean [%] 60.9 28.2 13.4 6.8 3.5 1.9 1.1 0.6 0.3 0.2
Median [%] 67.1 20.4 13.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0
Max [%] 99.9 99.8 99.7 99.7 99.6 99.5 99.0 60.7 44.3 36.2
Table 3.2: Percentage of data points for which the three-dimensional prostate displacement
exceeds a specified threshold value in the whole data set.
Displacement [mm] 1 2 3 4 5 6 7 8 9 10
Fraction of data [%] 61.0 28.5 13.5 6.9 3.5 2.0 1.1 0.6 0.3 0.2
Table 3.3: Calculated CTV-to-PTV margins for different fraction times of 15 patients. This
data is shown as part of fig. 3.10.
Duration [min] 1 2 3 4 5 6 7 8 9
Margin [mm] 1.0 1.4 1.9 2.2 2.5 2.8 3.0 3.3 3.5
der, while the median is 0.0% for displacements larger 5mm. As the maximum values show,
single fractions can have large deviations, which can lead to strong dosimetric consequences,
when not corrected for.
Summing up all fractions to one data set, 61% of data points show a three-dimensional
prostate displacement above 1mm. This percentage decreases to 0.2% for a displacement
of 10mm. All values are shown in table 3.2.
3.3.1.2 Margins for different treatment times
The margins determined for 15 patients are shown in table 3.3. The margin sizes calculated
for 10 and 15 patients are almost the same, the values for 10 patients differ maximum
0.1mm. In fig. 3.10, the trend over time is shown for the 15 patient analysis. Additional to
the margin, the standard deviation of the systematic error Σd and the standard deviation
of the random error σd of prostate displacement is displayed for each treatment time d. The
standard deviation of the random error is always larger than the standard deviation of the
systematic error. But after 3min of treatment the systematic component dominates the
margin size. This is due to the weighting in the margin calculation (Md = 2.5Σd + 0.7σd)
and the different slope of their time dependence. The margin increases almost linear in the
analyzed time range: Beginning with 1mm for 1min until 3.5mm for 9min for each minute
of treatment approximately 0.3mm additional margin has to be considered.
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Figure 3.10: Treatment time dependence of the SD of the systematic and the random prostate
displacement shown together with the resulting margin.
Table 3.4: Margins for both IGRT positioning methods and in combination with intrafraction
motion for a fraction time of 9min.
Scenario Margin [mm]
Anatomic MV CBCT match, setup only 7.6
Marker based MV CBCT match, setup only 5.6
Intrafraction motion for 9min 3.5
Anatomic MV CBCT match and intrafraction motion 8.6
Marker based MV CBCT match and intrafraction motion 6.8
3.3.1.3 Margins for IGRT positioning strategies
There can be large differences between image registration based on bony anatomy and
markers in the prostate. This differences originate from prostate motion relative to the
bone structure. An example of these deviations can be seen in fig. 3.11. There is shown
an image fusion of a transversal slice of the planning CT and the corresponding slice of a
fraction MVCT, after registration of the three beacons.
The derived isotropic CTV-to-PTV margins for the individual positioning methods are listed
in table 3.4. A reduction of required margin size from 7.6mm to 5.6mm can be achieved by
using fiducial markers in the prostate for image registration instead of the bony anatomy.
Combining these setup margins with prostate displacements due to intrafraction motion for
9min of treatment from section 3.3.1.2, by adding the corresponding Σ and σ quadratically,
the resulting margins show an increase from 6.8mm to 8.6mm, when switching from marker
based to bone based positioning.
The assumption of the Calypso position as ground truth does not take into account the
motion occurring during the time gap between the acquisition of the MV CBCT and the
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Figure 3.11: Planning kVCT (red) and position verification MVCT (green) fused after beacon
match. All three beacons are aligned and the bones show large deviations. Only one of the
beacons can be seen here.
Calypso localization. For this reason the given values are a combination of setup errors and
approximately 5 min of motion, which is a realistic time difference between CT acquisition
and start of therapy in IGRT as well.
3.3.2 Experimental validation of 4D dose reconstruction
3.3.2.1 Comparison of measured and calculated dose
The comparison between the moved films and the corresponding slices of the calculated
‘moved’ dose distributions using the target point shifting method shows a minimum 3 %/
3 mm local γ-index of 91.4%. Using the convolution methods the γ-indices for three patients
are above 90% too, but for the patient with the largest intrafraction motion they decrease
to 89%. Data for all patients can be found in table 3.5, where values for the static cases
are additionally listed for comparison. As mentioned above, the best fitting transversal slice
of the calculated dose distributions was determined from the target point shifted plans for
the moved films. Using one of the convolution methods for the selection of the best fitting
slices lead to a maximum deviation in slice coordinate of 0.5mm. A comparison based on
these slices does not change the ranking in calculation methods and increase the γ-indices
obtained for the convolution methods below 0.2%. Thereby the differences between γ-indices
determined for adjacent slices are well below 0.3% for the whole considered longitudinal
region.
An example of dosimetric consequences which can occur from intrafraction motion is shown
in fig. 3.12. The delivered monitor units for the phantom were the same as for the patient,
leading to a maximum dose of 105Gy in the phantom with a diameter of 20 cm. It can be
seen that measured and calculated motion impacts on the dose are similar. For the absolute
difference values, it has to be considered that the used corresponding slices of calculated
dose distributions have a difference of 1.25mm in the longitudinal coordinate, resulting from
the search of best fitting plan slice, described in section 3.2.4.2. This leads to a combined
effect of intrafraction motion and longitudinal dose gradients.
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Table 3.5: 3%/3mm γ-indices for the comparisons between the calculated dose distributions
and the corresponding films together with the mean prostate misplacement. The patient number
P refers to the group of 21 patients used in the dose recalculation based on patient CTs and
treatment plans.
Mean Whole data set Beam-on Target point Static
prostate convolution convolution shifted plan plan
misplacement vs. vs. vs. vs.
P [mm] Moved film [%] Moved film [%] Moved film [%] Static film [%]
2 1.7 95.6 95.8 96.3 96.3
3 1.4 93.1 93.6 93.4 94.5
6 1.1 94.0 94.0 94.8 98.6
7 2.8 89.2 89.6 91.4 94.1
 
 
(a)
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Figure 3.12: Measurement: Difference between the moved and the scaled static film for pa-
tient 4 (a). Calculation: Difference between the corresponding transversal slices of the ‘moved’
plan (target point shifting method) and the static plan for patient 4 (b). The color map scale
is in Gy for a maximum phantom plan dose of 105Gy.
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Table 3.6: γ-indices for the comparisons between the calculated dose distributions in the plan
slices related to the moved films.
Whole data set Target point Target point
convolution shifted plan shifted plan
vs. vs. vs.
Beam-on Whole data set Beam-on
convolution [%] convolution [%] convolution [%]
Patient 3 %/3 mm 1%/1mm 3 %/3 mm 1%/1mm 3 %/3 mm 1%/1mm
1 100 100 100 95.5 100 96.1
2 100 99.1 100 93.7 100 96.1
3 100 100 100 91.7 100 89.0
4 100 100 99.6 77.5 99.5 77.9
3.3.2.2 Comparison of calculated dose distributions
The two convolution methods show no difference for the plan slices related to the films
between each other beside a decrease to 99.1% in one patient using a 1 %/1 mm local γ-
index. All other 3 %/3 mm and 1 %/1 mm γ-indices are 100%. The comparison between the
plans recalculated with shifted target points and the convolution methods reach minimum
3 %/3 mm local γ-indices of 99.5%. The differences between these methods in the homoge-
neous phantom get only visible when a 1 %/1 mm local γ-index is used. Then, the values
range from 77.5% to 96.1%. All γ-indices are shown in table 3.6.
3.3.3 Dosimetric consequences on prostate IMRT
In the following section, results for the comparisons between the ‘moved’ and static fraction
doses and cumulative doses for 21 patients are presented, they are summarized in table 3.7.
The mean prostate displacement was 1.7mm in average, for single fractions it was up to
7.4mm. 1
The 3D γ-evaluation for the ‘moved’ fractions against the static ones resulted in an average
γ-index of 83.6%, with a minimum of 27.2%. The γ-indices for all fractions are shown
in fig. 3.13(a). Applying a plan acceptance criterion of a 3 %/3 mm γ-index of 90%, only 154
of all 717 single fractions would pass (21.5%). Combining single fractions to the cumulative
dose distributions for each patient the average γ-index was 86.4% with a minimum of 77.7%.
1Additional to the geometrical mean a dose weighted mean prostate misplacement was calculated. For the
dose weighted mean each segment’s mean displacement was weighted with the product of the segment’s
field size and monitor units to account more for segments with more applied dose to the patient. There
was no statistical difference between the geometrical mean and the dose weighted mean prostate mis-
placement, so all values in table 3.7 refer to both, even the range is the same. Calculating single fraction
displacements, there were differences up to 0.4mm between the two measures. For the cumulative values,
the maximum difference is 0.1mm. If these dose weighted mean prostate misplacements are used for
correlation analysis, the changes in correlation coefficients are small, ranging from −1.1% to 2.8%.
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Table 3.7: Results of the comparison between static plans and ‘moved’ dose distributions for
single fractions and cumulative dose distributions per patient for 21 patients. r is Pearson’s linear
correlation coefficient between the dosimetric endpoint and the corresponding mean prostate
misplacement. All correlations have p-values < 0.01.
Mean ± SD Range r
Fraction mispl. [mm] 1.7 ± 1.0 (0.3, 7.4)
Cum. mispl. [mm] 1.7 ± 0.5 (0.9, 2.8)
Fraction γ-indices [%] 83.6 ± 9.3 (27.2, 96.8) -0.94
Cum. γ-indices [%] 86.4 ± 4.6 (77.7, 94.7) -0.88
Fraction boost D95% [%] -0.9 ± 2.1 (-26.7, 1.8) -0.68
Cum. boost D95% [%] -0.3 ± 1.1 (-4.4, 0.7) -0.72
Fraction PTV D95% [%] -2.0 ± 3.4 (-24.9, 2.4) -0.82
Cum. PTV D95% [%] -1.2 ± 1.5 (-4.2, 1.4) -0.72
The cumulative dose distributions for 6 of 21 patients pass the 90% criterion. Data for all
patients can be seen in fig. 3.13(b).
The change in D95% of the boost volume for single fractions was on average −0.9% with a
maximum change of −26.7%. For the PTV these values are −2.0% and −24.9%. Values for
all fractions are shown in figs. 3.13(c) and 3.13(e). A change of D95% of the boost volume
of more than 1, 3 and 5% occurred in 32.1, 7.1 and 3.6% of all fractions, respectively.
The corresponding PTV data are 50.2, 19.9 and 9.9%. Combining single fractions to the
cumulative dose distributions for each patient the change in D95% of the boost volume was
on average −0.3% with a maximum change of −4.4%. The cumulative dose distributions
lead to a mean change in D95% of the PTV of −1.2% with −4.2% maximum change. Data
for all patients can be seen in figs. 3.13(d) and 3.13(f). The change of D95% of the PTV
for the cumulative dose distributions were larger than 1, 3 and 5% for 10, 4 and 0 patients,
respectively. For the boost volume these values are reduced to 2, 1 and 0 patients.
Analyzing the correlation between motion amount and change in dose distribution, best
correlation (r = −0.94) was reached by the single fraction γ-index. For the single fraction
evaluation of the change of D95% of the boost volume and the PTV the correlation was
smaller with correlation coefficients of −0.68 and −0.82. For the cumulative dose distribu-
tions these values are −0.88, −0.72 and −0.72.
Correlating the change in D95% of the PTV and the boost volume lead to correlation coef-
ficients of 0.78 for the single fraction doses and of 0.65 for the cumulative dose distributions
(both have p-values < 0.01). The linear regression between these parameters show a slope
of 0.47 to 0.48, representing an effect in the boost volume of about one half compared to the
PTV. All data for the comparison of boost volume and PTV change in D95% are shown in
fig. 3.14. As indicated, we observed that for one patient the boost volume change is larger
as for the PTV, see fig. 3.14(b). 11 of the 12 fractions with a boost volume D95% change of
more than 8% depicted in fig. 3.14(a) belong to this patient. It is the one with the largest
amount of motion observed. Furthermore, the posterior margin for this patient was reduced
to about 3mm during the planning process instead of the general margin concept of an
isotropic 7mm boost-to-PTV margin.
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Figure 3.13: Results of the dose comparisons for single fraction plans (a,c,e) and cumulative
plans for whole treatment courses (b,d,f).
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Figure 3.14: Change in D95% of the boost volume plotted against the change in the PTV for
all fractions (a) and for the cumulative patient plans (b). All data points of the patient, for
which the cumulative change in PTV D95% is smaller than in the boost volume are marked with
a cross.
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Figure 3.15: Cumulative dose volume histograms for the boost volume and the PTV for the
patient with the largest amount of motion. The static cases are shown together with the ‘moved’
dose distributions. For fraction 29, the outlier in fig. 3.14(a), large perturbations can be seen
(a). While the effects for the whole treatment course are much smaller (b).
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To illustrate the dosimetric effect in this pre-mentioned patient with the largest motion
amount, cumulative dose volume histograms (dvh) are shown in fig. 3.15 for the single
fraction with the strongest dose perturbation and for the whole treatment course.
3.4 Discussion
3.4.1 Quantification of prostate motion and its impact on margin sizes
The intrafractional motion patterns containing drifts and spikes in longitudinal and verti-
cal direction reported here are in agreement with published data (Kupelian et al., 2007;
Langen et al., 2008b). The overall motion amount from these individual fraction shapes is
determined for all three directions and in 3D. Comparing the unidirectional analysis with
data from (Li et al., 2008a) for 35 patients a more stable mean position over time for lon-
gitudinal and vertical direction is reported there with deviations about 0.4mm in inferior
and posterior direction after 9min of treatment without clear trend in time. While here
the mean inferior and posterior deviation after 9min is 0.9mm and 0.8mm with a clear
trend. The standard deviations after 9min around these means show similar sizes with
lateral, longitudinal and vertical values of 0.7, 1.6 and 2.0mm in (Li et al., 2008a) and 1.0,
1.9 and 2.0mm here. The analysis of three-dimensional prostate displacement in terms of
percentage of time, a given value is exceeded per fraction can be compared by data of 17
patient in (Langen et al., 2008b). The mean values reported there for displacements above
3, 5, 7 and 10mm, are 13.2, 3.1, 0.8 and 0.0%, respectively. They are only slightly smaller
than the ones reported here with 13.4, 3.5, 1.1 and 0.2%. The median values for the same
displacements are 13.2, 0.0, 0.0 and 0.0% in this thesis, the values reported in (Langen
et al., 2008b) (1.4, 0.0, 0.0 and 0.0%) show a positively skewed distribution with a much
larger proportion of fractions with only a few points in time exceeding the 3mm.
The CTV-to-PTV margins derived from the patient’s intrafractional prostate motion can
be compared with two analysis (Tanyi et al., 2010; Li et al., 2013) in which the Calypso
System is used for motion monitoring as well. In (Tanyi et al., 2010) treatments of 14
patients with fraction times between 8 and 16min are evaluated without differentiation
between different treatment times. From the data of their analysis a three-dimensional
margin of 3.8mm can be calculated. Our evaluation results in a margin of 3.5mm for 9min
of treatment. Considering the unclear distribution of fraction times in the mentioned time
interval for (Tanyi et al., 2010), these values are in good agreement. An analysis regarding
time trends in margin sizes is presented in (Li et al., 2013). They used data from 105
patients with treatment times ranging from 8.1min to 24min with a median of 11.5min.
From their data margins of 1.6 and 1.7mm for 3 and 5min of treatment can be calculated.
The corresponding values for our patient data are 1.9 and 2.5mm, which shows a much
larger increase in time. Li et al. additionally reported on a saturation in margin size after
9min of treatment, which can not be analyzed with our data.
Most published evaluations of the difference in patient positioning strategies based on image
registration using bony anatomy or implanted fiducial markers using the marker based
registration as ground truth prostate position, e.g. (Nederveen et al., 2003; Langen et al.,
2005). Because of that, they are not suitable for comparison with the data presented here.
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In this thesis the Calypso localization serves as ground truth for both methods. This is also
the case for an analysis in (Tanyi et al., 2010), where daily kV cone beam CT data sets are
used for image registration with the planning CT. The marker based image registration leads
to a 3D margin of 4.2mm for the data published by Tanyi et al. and 5.6mm in our case. For
the image registration based on bony anatomy the difference is much larger with a value of
13.6mm for Tanyi et al. and 7.6mm for our patient data. Between the two reports, there
are two differences beyond the imaging technique (kV versus MV CBCT): first, a larger slice
thickness of the kV CBCT in Tanyi et al. (2.5mm compared to 0.54mm) and second, the
consideration of the pelvis in the bony anatomy match, only for Tanyi et al. while in our
evaluation the whole bone structure is considered. The enlarged slice thickness can lead to a
larger uncertainty in transponder position detection. While the difference in bone matching
should lead to a better result for Tanyi et al. in principal, because a better correlation
between pelvic and prostate position than on whole bone structure and prostate position
can be assumed. This is because the femoral heads can be in another position relative to
the pelvis in both image sets, which complicates the registration procedure. These results
allow for the conclusion, that the interfractional bone-prostate relation is more stable in our
patient cohort than in the one used in (Tanyi et al., 2010). The origin of this difference
between the patient cohorts is unknown, Tanyi et al. does not report information about a
dietary protocol or some details about the weight or the general conditions of the patients.
For application of CTV-to-PTV margins in clinical practice, some points have to be consid-
ered.
First, beside the requirement to be large enough to enable curative dose to the target volume,
the margin should be as small as possible to guarantee best dose sparing of the organs at
risk. The patient subjective reduction in side effects due to smaller margins is shown in a
trial with patient setup using the Calypso System and therefore reduced margins (Sandler
et al., 2010).
Second, all reported margins in this chapter account for patient positioning or intrafrac-
tional motion, only. Other geometrical uncertainties, e.g. from the treatment machine or
target delineation have to be assessed additionally. The resulting applied margins in clinical
practice are of the same size as the margins calculated here for compensation of inter- and
intrafractional motion, only. As described in section 3.2.1, the margin concept at the dkfz is
an integrated boost concept with a 7mm low dose margin. Other authors report the follow-
ing values for classic isotropic CTV-to-PTV margins with a reduction in posterior direction
to reduce rectal toxicity: 7mm overall with 4mm posterior margin in (Tanyi et al., 2010),
10mm overall margin with a reduction to 7mm in posterior direction in (Thongphiew et al.,
2009) and 8mm overall margin with 5mm posterior margin in (Huang et al., 2002).
Third, there are some publications arguing that CTV-to-PTV margins according to the
recipe proposed by van Herk et al. which is used here, are larger than necessary. One
reason is the assumption made by van Herk, that the prescribed dose is shaped accurately
and with very steep dose gradients around the PTV. This assumption is not fulfilled for
overlapping beams from multiple angles (McKenzie et al., 2000), under these conditions a
slightly blurred dose distribution is delivered, which acts as an additional margin. This
results in the need of a smaller factor for the random component of the margin recipe.
Another publication conclude the overestimation of margins with the van Herk formula
even in the presence of additional deformation and rotation of the prostate (Mutanga et al.,
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2011). Ballhausen et al. proposed a higher order correction for the Gaussian approach
used to describe time dependent random errors in van Herks margin recipe (Ballhausen
et al., 2013). They assume a random walk model of intrafractional prostate motion, which
is shown to be consistent with empirical data. This random walk model leads to a Gaussian
distribution of displacement in any direction for every point in time with varying mean
and increasing standard deviation over time. Calculating the fraction average displacement
distribution results not in another Gaussian distribution but in a Brownian distribution.
A Brownian distribution has a steeper, narrower shape as a Gaussian distribution with
the same variance. The incorporation of this correction in van Herks margin recipe leads
to a reduction of the random component of CTV-to-PTV margins for compensation of
intrafractional motion of about 30%.
3.4.2 4D dose accumulation
Dose reconstruction using a convolution of the static dose distribution with a probability
density function (pdf) of the target position is a known method (Lujan et al., 1999; McCarter
and Beckham, 2000). To account for interplay effects between patient motion and leaf or
gantry motion, this pdf can be applied per IMRT segment or per beam instead of using the
data of the whole treatment (Li et al., 2008a,b; Adamson et al., 2011). Even the problem
of tissue inhomogeneities (Craig et al., 2003a) in the patient is sometimes avoided by a
convolution of the fluence maps before the dose calculation instead of the dose convolution
(Beckham et al., 2002). But all these approaches lead to statistical uncertainties in dose
estimation due to the finite number of data points in the pdf (Craig et al., 2003b), especially,
if the convolution is performed segment-wise. In this thesis the two convolution methods
were used to evaluate a possible difference in motion systematic between beam-on phases
and beam breaks and to quantify the interplay effects through the comparison with the
target point shifting method.
Approaches without convolution methods use different concepts of motion consideration.
For example, in a calculation where the prostate is translated and rotated in a static dose
cloud (Noel et al., 2010), which makes the assumption that only the prostate is moving in a
rigid body frame. Another possibility is to treat the whole patient as rigidly moving together
with the prostate, like in the method by Waghorn et al. (Waghorn et al., 2010). There, the
fluence maps were exported from the treatment planning system and shifted accordingly to
the prostate misalignment per monitor unit. The re-imported fluence maps were then used
for dose calculation on the static CT.
Our calculation methods for ‘moved’ dose distributions assume a rigid patient, too. Thus,
our dose distributions are an estimate whose agreement with the real delivered dose will
differ from patient to patient. Using the Calypso System, no information is available about
the relative motion of prostate and bony anatomy or seminal vesicles. The prostate shifts
detected by the Calypso System were used as shifts of the whole rigid patient, this leads
to some limitations of the calculation methods, which are discussed in the following. First,
shifts between the bony anatomy and the prostate are not accounted for. (Palombarini et al.,
2012) studied these shifts by a comparison of bone registration and soft-tissue registration
of daily kV CBCT and planning CT in 18 patients. Considerable deviations were found in
AP direction, namely 2.7mm systematic and 2.8mm random variation. Second, in our large
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PTV margin, the base of the seminal vesicles is included as target, so it is arguable how
they move relative to the prostate. Third, the effects of prostate rotations and deformations
by physiological processes has to be viewed. (van der Wielen et al., 2008) evaluated data of
21 prostate patients with implanted fiducial markers, receiving four CT scans each. They
reported on residual deviations of the prostate (≤ 1.3 mm) and the seminal vesicles (≤
3.4 mm) using only translations for image registrations between the first and the following
CTs, originating in deformations and rotations. These deviations describe the interfraction
changes, so it can be assumed, that the intrafraction changes are much smaller. This data
refer to the whole seminal vesicles, we consider only their base, so the effect will be even
smaller. Altogether it can be assumed, that the dose estimation is best for the smallest
amount of motion. This should be considered when looking at results for fractions with a
large amount of motion. Whether these factors lead to an over or under estimation of the
effect of intrafraction motion in general is not clear, this depends on the individual patients
anatomy.
3.4.2.1 Experimental validation of 4D dose reconstruction
It has been demonstrated that the method of shifting the target point for every segment
in a recalculation of the static plan is well suited to calculate ‘moved’ dose distributions.
3 %/3 mm local γ-indices above 90% were achieved in comparison with measured doses for
all considered patients. For comparison, we performed a convolution of the static dose with
two different pdfs containing either all Calypso motion data or only the motion data during
the beam-on phases. These method leads to good results, too (minimum 3 %/3 mm local
γ-index of 89% against the moved films).
The validation of calculation methods for ‘moved’ dose distributions are managed differently
in the literature. For the comparison other calculation methods (McCarter and Beckham,
2000; Noel et al., 2010) or measurements (McCarter and Beckham, 2000; Waghorn et al.,
2010) can be used. Inter-calculation comparisons have the potential to lead to a better
result than validations incorporating measurements, bringing in additional uncertainties
like phantom positioning and beam modeling in the calculation. Waghorn et al. reported
a minimum 3 %/3 mm γ-index of 97.4% for comparisons between film measurements and
their calculation method of shifting the fluence maps according to phantom motion prior to
dose calculation. This is larger than our minimum value for the target point shifting method
(91.4%), but the conditions of the measurements are also different. We irradiated whole
treatment courses containing 35 fractions on one film and used measured patient motion.
The film measurements in (Waghorn et al., 2010) are based on artificial sinusoidal motion
and a dose equivalent of one fraction. In that way, our measurements each lasting more
than 6 h are much more prone to accumulate small positioning errors and errors because of
an unperfect synchronization between radiation and phantom motion.
The two convolution methods agree much better when compared to the target point shifting
method. This shows the impact of interplay effects between patient motion and gantry and
MLC motion, which is not considered by our convolution methods. The differences between
dose distributions calculated with the two different convolution methods are very small. One
of them considers the irradiation pauses and the other does not, this allow for the conclusion,
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that the motion patterns in irradiation pauses are not mainly different from them during
the irradiation.
We decided to use the target point shifting method for the evaluation of dosimetric effects
of intrafraction motion in the analysis based on patient CT data. Besides the slightly better
validation results, this has two reasons, first this method accounts for interplay effects
between patient motion and beam delivery dynamics and second even with a pencil beam
algorithm for dose calculation used here, the heterogeneous patient anatomy should be
considered more explicitly than in convolution of a static dose cloud.
The presented dose recalculation tool of shifting the target point for every IMRT segment
can also be used to evaluate and compare different margin sizes and dose prescription con-
cepts using realistic patient motion patterns considering different approaches of adaptive
radiotherapy.
3.4.2.2 Dosimetric consequences on prostate IMRT
The calculation of ‘moved’ dose distributions for single fraction plans and cumulative dose
distributions representing a whole treatment course shows four main results: 1) In some
fractions, large changes in dose are induced by intrafractional motion. This is consistent
with other publications (Li et al., 2008a; Langen et al., 2009, 2012). 2) A fractionation with
35 fractions reduce this effect considerable, as can be expected from theoretical assumptions
(Bortfeld et al., 2002). 3) The boost volume is in average much less effected than the PTV,
which has to be expected and justifies the margin concept. 4) Correlation between motion
amount and dose deviation is strong using the three-dimensional 3 %/3 mm γ-index, but
decreases using the volume specific change in D95%.
To discuss our results in detail, we compare them with (Langen et al., 2012) in which dose
recalculations for prostate patients for seven field step-and-shoot IMRT irradiations were
done by shifting the fluence maps before dose calculation. They used plans with a classic
CTV and PTV concept with a 5mm CTV-to-PTV margin with exception of a posterior
margin of only 3mm. A comparison of margin concepts can be seen in fig. 3.16. In both
concepts, there is an ‘inner volume’ and an ‘outer volume’, these are boost and PTV for this
work and CTV and PTV for Langen et al. The motion data used by Langen et al. was the
same as in another publication of the same group (Langen et al., 2008a). The amount of
time the prostate misplacement exceeds 3, 5, 7 and 10mm mentioned there is only slightly
smaller than in our data. Due to that, the comparison of the dosimetric effect determined
by them with the ones found in this work, can be used to evaluate dose sensitivity against
intrafraction motion for both irradiation concepts (classic CTV-PTV and integrated boost).
The reported dose effects using the change of D95% in inner volume and PTV are smaller
than ours, both for single fraction plans and for cumulative plans. They report on maximum
single fraction deviations in the CTV and PTV of up to−6.4% and−12.7%, while the values
are −26.7% and −24.9% for our boost volume and PTV. The comparison of mean values
and standard deviations is shown in table 3.8. In general, their average effects in single
fractions and cumulative dose distributions are smaller than ours. The largest discussed
dose perturbation is calculated for our PTV. This is constructed as a region of two dose
levels with a high-dose volume in the middle, which complicates a comparison to the other
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Figure 3.16: Margin concept used in (Langen et al., 2012) (left) with 3mm posterior and
5mm elsewhere and in this work (right) with 7mm isotrop. Gray values indicate relative levels
of prescribed dose per concept: The same prescribed dose for CTV and PTV (left) and a higher
dose in the boost, than in the PTV (right). CTV and boost volume are later referred to as
‘inner volume’.
Table 3.8: Comparison of the change of D95% in different volumes. The cumulative dose dis-
tributions sum up 25 fractions in (Langen et al., 2012) and 35 fractions in this report. Inner
vol. serves as abbreviation for CTV and boost volume for both studies, respectively.
(Langen et al., 2012) This report
Dosimetric endpoint Mean ± SD [%] Mean ± SD [%]
Fraction inner vol. D95% -0.2 ± 0.5 -0.9 ± 2.1
Cum. inner vol. D95% 0.1 ± 0.2 -0.3 ± 1.1
Fraction PTV D95% -0.5 ± 1.1 -2.0 ± 3.4
Cum. PTV D95% -0.2 ± 0.2 -1.2 ± 1.5
volumes. The differences in PTV effects can be illustrated by looking at the percentage of
fractions, in which the PTV D95% is altered by more than 1, 3 and 5%. In the current
report, the values are 50.2, 19.9 and 9.9%, in the report by Langen et al. they are 12, 2.5
and 0.8%.
Studying the correlations between motion amount and dose perturbation, high correlation
coefficients were found using the three-dimensional γ-index as dosimetric endpoint (-0.94 for
single fractions and -0.88 for cumulative plans). For correlation comparison with (Langen
et al., 2012), the correlations with the geometric mean displacement were used for both
studies. Correlation data are published for single fraction evaluations only. The change in
D95% of the PTV is better correlated to the motion amount than the change in D95% of
the inner volume, for both investigations. A decrease in correlation coefficients from −0.7
to −0.26 is reported there and our calculations give −0.82 and −0.68. In this comparison
another important point can be anticipated. This is the correlation of D95% change in the
PTV with the change in D95% of the inner volume. The single fraction changes in D95% of
CTV and PTV in (Langen et al., 2012) have a poor correlation coefficient of +0.53, which is
together with the smaller change in the D95% of the CTV a reason to say that their margin
protects the CTV properly against motion caused perturbation. In our case the correlation
between the changes in the PTV and the boost volume is stronger (r=+0.78). This is
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an effect of the lower dose in our margin. Depending on the dose gradient between boost
volume and PTV, almost all motion has influence on the PTV and the boost volume. There
is no threshold for the boost volume, like in a classic CTV-to-PTV margin concept. The
change in the boost volume are on average half of them in the PTV or lower, so this margin
concept, using a large margin with less dose, is also appropriate for protecting the inner
volume. But it has to be noted, that the dkfz margin concept was developed for a therapy
using MV CBCT based patient setup, which leads to additional uncertainties, while the
current investigation assumes intrafractional motion only. When considering interfraction
motion in addition, the deviations between planned and recalculated dose distributions are
expected to be larger.
There is one patient in our analysis, for whom the effects in the boost volume are remarkable
and even larger than in the PTV. This is possible because of the integrated boost concept,
where for the PTV motion a higher dose in the voxels near the boost volume can compensate
lower dose near the normal tissue in the calculation of the D95%. It has to be kept in mind
that this patient is the one with the largest amount of motion and therefore the assumption
of a rigid patient leads to the largest effect of calculation uncertainty.
We used a fractionation scheme with 35 fractions, this leads to a much smaller motion
induced perturbation of the dose distribution in the cumulative dose, than in the single
fractions. Hypofractionation for prostate carcinomas is discussed and used for some time,
especially because of the radiobiology of prostate tumors (Madsen et al., 2007; Ritter et al.,
2009). Such a treatment scenario has two characteristics: less number of fractions and an
increased treatment time per fraction. Both can lead to a larger effect of intrafraction motion
on the dose distribution. The less number of fractions will lead to a smaller interfractional
averaging effect. The increased fraction time can have two opposing effects. First some
dose perturbation will be averaged out, like due to many fractions. But second, potential
longitudinal and vertical prostate drifts can result in an increased prostate displacement at
the end of each fraction, if no repositioning procedure is performed during the fraction. The
increase of motion amount with fraction time was shown for a subset of our patient data
for durations between 2 and 9min in section 3.3.1.2.
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4 Motion monitoring in lung radiotherapy:
Challenges and chances
Electromagnetic tracking offers the possibility to monitor three-dimensional lung tumor mo-
tion continuously in real-time during radiation therapy without additional imaging dose for
the first time and without the need of a special treatment device. In this chapter the in-
vestigations we made as part of the first trial evaluating the clinical use of the anchored
Calypso beacons for lung tumor patients are presented. They regard the intrafraction mo-
tion and interfractional changes of it. No evaluation of setup accuracy was made, as the
system was not used for patient positioning in this trial. In a first part we targeted on
quantification of the motion reported for the transponder centroid, secondly the relative
motion of implanted transponders during fractions and changes of the transponder geome-
try over the whole course of treatment were determined to proof the underlying assumption
of a stable transponder geometry. In a third part the correlation between the intrafraction
motion measured with the Calypso System and the Anzai belt was evaluated, thereby only
the transponder centroid motion was used.
Parts of the following investigations were presented at scientific conferences (Schmitt et al.,
2013a,b).
4.1 Clinical background and purpose
With a proportion of 7.0% and 13.8% of all newly detected cancers, lung cancer is for both
women and men the third most common cancer in Germany. In absolute values about 15600
women and 34000 men were diagnosed with lung cancer in 2008. The mean age at diagnosis
is 68 and 69 years for women and men, respectively. The relative 5-year survival rates are
rather poor with 19% for women and 15% for men. This leads to deaths caused by lung
cancer of nearly 13000 in women and 30000 in men in Germany in 2008, denoting the third
most cancer deaths for women and the first rank in cancer deaths in men. In the last few
years, an increase has been seen in lung cancer in women and a decrease in men, which is
usually explained by an equalization of smoking behavior in both sexes. (RKI, 2012)
Radiotherapy is one option of curative therapy for lung cancer patients. All patients en-
rolled in our lung study were diagnosed with non-small cell lung cancer (NSCLC). In early
stages of this disease surgery provides best outcome and is thereby first choice, possibly
in combination with chemotherapy. A radiotherapy is only performed if the tumor is in-
operable, or if the surgical resection was incomplete. In later stages treatment regimens
combining chemotherapy, surgery and radiotherapy or chemotherapy and radiotherapy are
applied. (Hansen and Roach III, 2010; Oertel et al., 2010)
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Lung tumor motion is mainly induced by respiration and due to that not avoidable, this
leads to the need of dedicated managing techniques for the intrafractional as well as the
interfractional motion. These techniques rise the ability to tailor the irradiation fields more
precisely to the target volume (smaller margins). Therefore the volume of healthy tissue,
receiving high irradiation doses can be reduced. This volume reduction offers the opportu-
nity to increase the dose to the tumor, while the side effects due to irradiation of healthy
lung tissue remain acceptable (Nelson et al., 2006). Higher radiation dose to the tumor has
shown to enlarge the local tumor control and the overal survival time for NSCLC patients
(Kong et al., 2005).
The intrafractional motion is dominated by the approximately periodic breathing motion
around a mean position, here called midline. Additionally the amplitude can vary during
the fraction and the midline position can change over time, e.g. periodically or as a drift.
The interfractional motion can have different aspects, too. For example the tumor midline
position and motion amplitude can change from day to day typically due to different organ
filings, e.g. of the stomach or from treatment related changes in anatomy or lung function.
Some of these changes can be compensated for by the daily patient positioning procedure if
the tumor position relative to the organs at risk has changed only slightly. While other inter-
fractional changes like extensive tumor shrinkage can only be regarded through a replanning
process.
There are several devices available for patient positioning and intrafractional detection of
breathing motion, see section 2.2.2. Many of these detection devices use an external surro-
gate, like motion of the chest wall instead of the tumor motion. As shown by (Korreman
et al., 2008), it is not possible to use smaller margins in gated therapy than in ungated
when the gating information is based on an external breathing signal, only. It is concluded
that internal tumor motion has to be monitored because of shifts in the tumor baseline (i.e.
tumor position at end of exhale) and phase shifts between external and internal motion. All
established methods for detection of internal lung tumor motion are based on imaging with
the treatment beam or give an additional imaging dose to the patient. This often requires
implantation of fiducial markers for reliable and fast motion detection. For this marker
implantation several methods are developed in the last years, the standard approach is the
percoutanuos implantation under CT guidance, like described by (Whyte et al., 2003), which
has the drawback of a risk of pneumothorax of up to 45% (Kothary et al., 2009).
With the development of new Calypso transponders for the use in lung radiotherapy, see
section 2.2.2.2, Varian provides the first system for electromagnetic tumor tracking for lung
cancer patients. These transponders are implanted via a standard bronchoscope. To bring
each transponder as close to the tumor as possible, the catheter with the transponder exits
the bronchoscope under continuous X-ray guidance to deposit it in a small airway.
In this chapter real-time 3D motion data acquired with the Calypso System was quantified
enabling a comparison with image guided methods. The continuous 3D data of up to 30
fractions also allows for evaluations of the tumor midline and motion comparison between
fractions.
For treatment techniques, using an active tracking of the tumor (either moving the beam or
the patient) usually a prediction of future tumor position from actual position is necessary
because of system latencies. The quality of this prediction increases the more regular the
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motion is. To get an impression on this regularity over single treatment fractions, data from
two patients are analyzed in consecutive time intervals. Thereby the focus is on differences
between beam-on phases and beam breaks.
For image guided marker based motion management often more than one marker is im-
planted for better geometric reliability, e.g. (Shirato et al., 2003). These techniques usually
assume a rigid patient geometry in the analyzed region. When the Calypso System is used in
clinical routine, the centroid motion is the information which is available for online interven-
tion during the therapy, also assuming a stable transponder geometry during the irradiation
and over the whole course of treatment. Quantifications of deviations from this assumption
are rare, some evaluations of interfractional transponder distance changes are made for hy-
pofractionated therapy (Imura et al., 2005; van der Voort van Zyp et al., 2011). However,
especially for conventionally fractionated therapy over several weeks, a decrease in tumor
volume has to be expected. This decrease in tumor volume influences the geometry of the
surrounding tissue and hence the transponder geometry and therefore questions the relia-
bility of the centroid position as surrogate for the tumor position. Reported values are e.g.
a median GTV regression of 41.7% measured with weekly 4D CTs in eight patients over six
weeks on average (Britton et al., 2007) and a mean shrinkage of the primary GTV of 1.2%
per day determined for 10 patients using the TomoTherapy MVCT (Kupelian et al., 2005).
To our knowledge no analysis of continuous intrafraction data on inter-marker distances is
published so far. In this chapter the inter- and intrafractional variability of inter-marker
distances are investigated for three markers outside the tumor, detected continuously with
the Calypso System. The amount of deformation in the tissue of the upper lung is eval-
uated considering two aspects of transponder geometry variations: 1) due to intrafraction
breathing motion and 2) interfractional changes because of radiation effects in the normal
lung tissue and tumor shrinkage.
When external surrogate motion is used for motion management in lung radiotherapy, the
robustness of the relation between this external signal and the tumor motion itself is one
main point that has to be assigned individually for each external surrogate method. Here
the correlation between the changes in chest circumference due to breathing and the three-
dimensional motion of the beacon centroid was assessed.
4.2 Material and methods
4.2.1 Patient data
The lung patient data used in this thesis was collected during a multi-center trial for the
evaluation of anchored Calypso beacons organized by Varian Medical Systems, Inc. This
trial was approved by the ethics committee of the medical faculty of the University of
Heidelberg (approval number MZmu-026/2011) and has the title “Evaluating an anchored
transponder in lung cancer patients receiving radiation therapy”. The main objectives of this
study are the evaluation of the implantation procedure, position stability of the anchored
beacons over time and ability of the Calypso System to detect the beacons properly. All of
these evaluations will be done by Varian Medical Systems Inc. The investigations presented
in this thesis are additional work (also covered by the approval) using the collected data.
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The trial cohort contains seven patients, four of them with an upper lobe tumor and three
with a right middle lobe tumor, two got an additional chemotherapy, one before and one
concurrently to the radiotherapy.
The patient treatment was organized as part of a collaboration between the dkfz and the
Thoraxklinik at the University of Heidelberg. For all participants of this study, the implanta-
tion of the anchored Calypso beacons was performed at the Thoraxklinik bronchoscopically.
The treatment planning and the radiotherapy were done at the dkfz. For treatment plan-
ning several CT data sets were acquired: a kV 4D CT scan, a kV CT scan under free
breathing conditions and a kV CT scan in maximum exhale breath-hold position. The dose
prescription and calculation was done on the free-breathing CT, the other CT data sets de-
liver information for defining the ITV. For the treatment two different schemes are applied,
either a hypofractionated 3D conformal therapy with six beam angles and 10 fractions per
patient (for two patients in an early tumor stage without affected lymph nodes), or a step-
and-shoot IMRT with eight or nine beams in 30 fractions (for five patients). All of these
beam angles were coplanar. Prior to each fraction, a cone beam CT was acquired. For the
first 6 patients, this was an MV CBCT, for the last patient kV CBCTs were used after the
integration of a kV cone beam CT system at the Siemens Artiste gantry. The patients were
positioned according to the shift vector, determined between the daily CBCT data set and
the planning free-breathing CT. After the positioning was completed, the treatment was
performed during continuous motion monitoring with the Calypso System. The aforemen-
tioned set of CT image data, used for planning, was repeatedly acquired for every patient
once a week during treatment for control issues. Additional to the trial parts planned by
Varian, we had the opportunity to measure respiratory motion externally with the Anzai
chest belt (see section 2.2.2.3) for three patients.
Depending on the analysis, the following patient related data was used: I) kV 4D planning
and control CTs, II) Calypso motion data including beam status report and III) respiratory
signal, detected by the Anzai system.
4.2.2 Motion quantification
In this part of the investigation data from all seven lung patients was used. The fraction
data used from both fractionation schemes are the following: 20 fractions with a mean
duration from start of first beam until end of last beam of 4.5min for the hypofractionated
patients and 142 fractions with a more than doubled mean duration of 9.6min for the IMRT
patients. The determination of the breathing frequency was only feasible for five patients,
see section 4.2.2.2.
4.2.2.1 Overall displacement, midline changes and motion amplitude
All calculations were made for the unidirectional components and for the absolute value r
of the 3D positions, which is used in the following equations. First, a midline Mt of the
detected motion was calculated for each point in time t by a sliding mean of the positions
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r with a window width of 10 s, consisting of the data point rt itself and the 50 positions
before and afterwards:
Mt =
1
101
t+50∑
i=t−50
ri. (4.1)
This 10 s window covers approximately 2–4 breathing cycles. Motion analysis is made only
for the time between the start of the first beam and the end of the last beam. Only for
the midline determination, position data for the 5 s before and after this time interval was
used. The midline at the time irradiation starts ts for each fraction f is called initial midline
Mfinital of this fraction, M
f
initial = M
f
t=ts .
The intrafractional centroid displacement rfintra,t was calculated for each point in time of each
fraction relative to this initial midline as shown in eq. (4.2a). All fractions F per patient
were put together to calculate a mean and standard deviation of this overall intrafractional
centroid displacement. The equation for the mean is shown in eq. (4.2b). Thereby each
fraction f has a total number of data points T f from start ts to the end of irradiation te.
This measure represents the motion that has to be compensated if the patient would be
positioned to the breathing midline in the beginning of each fraction.
rfintra, t = r
f
t −Mfinitial, (4.2a)
rintra,mean =
F∑
f=1
te∑
t=ts
rfintra, t
F∑
f=1
T f
. (4.2b)
To analyze the motion characteristics, the intrafractional changes of the midline was de-
termined as well as the amplitude relative to it. The intrafractional midline motion was
determined similar to the overall displacement. The midline positions Mfintra,t relative to
the initial midline Mfinitial were calculated for each point of time between start and end of
irradiation of each fraction, see eq. (4.3a). For each patient a mean of the intrafractional
midline motion over all fractions was calculated, as shown in eq. (4.3b), as well as the corre-
sponding standard deviation. As for the overall displacement, these values were determined
for all three directions and in 3D. Two examples of longitudinal centroid motion and the
corresponding midline can be seen in fig. 4.1.
Mfintra, t = M
f
t −Mfinitial, (4.3a)
Mintra,mean =
F∑
f=1
te∑
t=ts
Mfintra, t
F∑
f=1
T f
. (4.3b)
The amplitude was measured as motion around this midline. Therefore, the distance be-
tween each inhale and exhale peak and the current midline for the corresponding time point
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Figure 4.1: Longitudinal motion and corresponding midline for one fraction of patient 1 (a)
and patient 6 (b). Motion data is presented for the time interval between start of first beam
and end of last beam, only. To illustrate the method and the motion patterns, two extreme
examples are chosen.
was calculated. From this data a mean amplitude for each fraction was determined in all
directions and in 3D. From these means a mean and standard deviation was calculated
for each patient. Thereby the standard deviations represent the interfractional variation of
mean breathing amplitude.
To illustrate the parameters introduced here for the beacon centroid motion, some examples
are given in the following. For a regular periodic breathing motion with constant inhale
and exhale position all unidirectional mean overall displacements would be zero, because
of compensation of positive and negative position values relative to the initial midline.
The standard deviation would be non-zero and its value depends on the inhale-to-exhale
distance. For the absolute value of the 3D overall displacement both mean and standard
deviation would be non-zero, because of no negative values in the averaging process. The
mean and standard deviation of the midline motion would be zero for all directions and for
the absolute value of the 3D midline, because stable midline is one of the characteristics of
the regular breathing. The amplitude would be half of the inhale-to-exhale distance in the
unidirectional cases and in 3D. All changes of this described regularity beside from slight
changes in breathing frequency have the potential to impede the averaging effects leading
to non-zero results for all parameters at least in the direction in which this variation occurs
and in 3D. These changes will arise from variations in inhale or exhale position or both,
leading also to a time dependent variation in motion midline as shown in fig. 4.1 for two
cases.
4.2.2.2 Breathing frequency
Additionally the breathing frequency was assessed from the motion data. This was done
using a fourier analysis. The frequency was determined from the unidirectional motion
with the highest amplitude for each patient. For each fraction the fourier transform was
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calculated and a gaussian fit was performed to the power spectrum. For each fraction the
mean of this gaussian fit was used as representation of the breathing frequency. From all
fraction means, a patient mean and standard deviation was calculated. For patient 3 and
7 all motion amplitudes are below 1mm, see table 4.1. Because of this, the noise from the
Calypso measurement dominates the fourier transform, which makes it inappropriate for
the determination of the breathing frequency. Three fractions of patient 6 could not be used
because of coughing periods inhibiting the extraction of the breathing frequency.
4.2.2.3 Motion differences between beam time and adjacent beam pauses
Data of patients 1 and 4 was used to evaluate differences in motion between subsequent
time intervals with and without beam delivery. These patients were picked because they
show the largest mean 3D amplitude and therefore effects would show up best. A schematic
of the fraction time line for one of the 3D conformal irradiations consisting of beams and
beam pauses is shown in fig. 4.2. In the beam pauses the gantry of the treatment device
is rotated to the next beam angle and the MLC aperture is adapted. The time line of a
step-and-shoot IMRT fraction has in general the same structure, but the beam blocks are
separated in segments with short beam pauses in between for adaption of MLC aperture
without gantry rotation. In this analysis the beam phase of each beam for the step-and-
shoot IMRT patient was defined as the time interval between the start of the first beam
segment and the end of the last beam segment. This leads to a similar pattern of beams
and beam pauses like for the patient receiving 3D conformal therapy. In general, the beam
pauses are shorter than the beams, especially for an IMRT treatment. To avoid an influence
of these different durations on the results of the following analysis, each set of motion data
from one beam pause was compared with two adjacent beam time intervals of the same
length. This is depicted in fig. 4.2, as well. These time intervals are called the first, second
and third interval related to each beam pause. For both patients the length of these intervals
is around 20 s.
For each of these intervals, two values were calculated for each motion direction for com-
parison. First the standard deviation of the beacon centroid position was calculated for a
comparison of general motion amount. Second the mean of the motion midline during these
intervals was evaluated for an analysis of beacon centroid drift. This midline mean was
calculated relative to the initial midline at start of the first beam as before.
4.2.3 Inter-transponder variations
Main parts of the following analysis of the transponder geometry were presented at the
annual meeting of the German Society for Medical Physics (Deutsche Gesellschaft für Medi-
zinische Physik, DGMP) 2013. With permission of the DGMP, this section and the corre-
sponding results and discussion is based on the abstract (Schmitt et al., 2013a), but modified
and extended in parts.
Data from six lung tumor patients is used for this investigation. These were patients 1, 2,
3, 4, 6 and 7, while patient 5 was excluded because of only two transponders usable for
electromagnetic localization. From these six patients, four have tumors in an upper lobe
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Figure 4.2: Schematic of an irradiation time line for 3D conformal therapy.
of the lung and two in the right middle lobe. Two patients received hypofractionated 3D
conformal radiotherapy with ten fractions and four a conventionally fractionated step-and-
shoot IMRT treatment. Average fraction time was 4.5min and 9.2min, respectively, with
a total number of 133 evaluated fractions. As described in section 2.2.2.2, each individual
transponder position is updated at a 3.3Hz rate. These single transponder positions were
made available to us for research purposes only. For all fractions, the time interval between
the first and the last beam-on signal was analyzed. The single transponder positions were
interpolated to 10Hz for getting position information at the same points in time for all
transponders. In fig. 4.3 a schematic of the transponder geometry is shown.
4.2.3.1 Intrafractional changes
Using the interpolated data, all inter-transponder distances in lateral, longitudinal and
vertical direction as well as the 3D distances were calculated. Means and standard devia-
tions (SD) of all data were computed for each fraction. The intrafractional variation was
quantified by the SDs of the lateral, longitudinal and vertical inter-transponder distances.
To analyze the reasons for large intrafractional changes, three correlations were evaluated
for the motion coordinate with the largest fraction SDs. As influencing parameters, the
transponder distances itself and the overall motion amount were analyzed as well as the
combination of both. First, the SD of the intrafractional inter-transponder distance was
correlated with the corresponding mean 3D inter-transponder distance for each fraction. A
second correlation was performed between the SD and the the mean 3D amplitude detected
for the transponder centroid in the corresponding fraction. Third, the SD was correlated
with the product of both quantities.
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Figure 4.3: Schematic of a transponder geom-
etry. Colors for identification of each inter-
transponder distance are as used in figs. 4.8
and 4.13.
4.2.3.2 Interfractional changes
Large interfractional changes in transponder geometry can make a replanning procedure
necessary. To quantify these changes, the variations of the area of the triangle spanned
by the transponders were analyzed. This was done in two ways: 1) From the transponder
distances determined in section 4.2.3.1, the area of the spanned triangle was calculated for
each point in time. For these areas, the means and standard deviations per fraction were
determined. 2) To check if the changes determined via electromagnetic localization can be
reproduced in the CTs as well, the area of the beacon triangle was derived from the CT
data sets for the two patients with the largest decrease in triangle area. For the read outs of
beacon positions the maximum exhale phase of each 4D CT data set was used, because they
are expected to show minimum motion artifacts. This is because of the large proportion of
breathing cycle time this phase is covering, see e.g. (Moorrees and Bezak, 2012). From each
data set the positions of all beacons were determined in all three directions and from their
distances the triangle areas were calculated.
Additional to these patient specific calculations, an average change in 3D inter-transponder
distances per day after first fraction over all patients was calculated from the Calypso data.
For this, a linear regression of 3D mean distance and day was done for all transponder pairs.
All 18 slopes (6 patients × 3 transponder pairs) of these regressions were then averaged.
4.2.4 Correlation between internal and external motion
For three lung patients (patients 5, 6 and 7) we had the possibility to monitor the chest
motion with the Anzai belt, see section 2.2.2.3, concurrently with the Calypso measurement.
For these three patients, the correlation analysis was made for 29, 23 and 25 fractions,
respectively. In sum, 7 fractions had to be excluded from the evaluations because of coughing
periods. The mean duration of the used fractions was 10.3min. Prior to the correlation
analysis, the data sets had to be synchronized and sampled to the same update rate, this
was done as follows. First, the different data sets were synchronized using the particular
beam-on status data, collected together with the motion data. To obtain these beam status
data, the Calypso System uses a detector for scattered radiation, while the Anzai system
gets beam status data directly from the accelerator control unit. Second, the Anzai data,
originally sampled with 40Hz are recalculated to the 10Hz pattern of the Calypso data.
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For each fraction the linear correlation coefficients r between the 3 unidirectional beacon
centroid motion data and the one-dimensional Anzai data was calculated.
To evaluate possible phase shifts between the signals, either due to the different methods of
beam status determination and sampling rate or due to anatomical or physiological effects,
these calculations were repeated with time shifted Anzai data. The Calypso time TC were
held fixed and the Anzai time TA were shifted in steps of 50ms forward and backward until
half of the mean breathing cycle time TBC was reached, −TBC/2 ≤ TC − TA ≤ TBC/2.
The breathing cycle time for patient 7, which could not be determined from the Calypso
data, was taken from the Anzai data reports. The correlation coefficients for each fraction
were averaged for each patient to mean correlation coefficients for each motion direction per
time shift to extract systematic shifts. The time shift corresponding to the best correlation
coefficient (largest norm of mean r), was then taken as phase shift.
This correlation analysis for whole fraction data sets does not consider intrafractional
changes in correlation between internal beacon centroid motion and external chest motion.
The correlation can vary over time because of changes in the breathing pattern or because
of patient motion leading to changes in the patient setup. Due to that, the data for whole
fractions represents averages of the time dependent correlation. When the external signal is
used as surrogate for the tumor motion, it is important to either guarantee a stable corre-
lation between internal and external motion or to update the correlation model frequently,
otherwise the applied dose distribution will differ from the planned one. To demonstrate
possible changes within a single fraction, the correlation is analyzed using a sliding window
covering three mean breathing cycle times (as proposed by (Ionascu et al., 2007)) for the
fractions with the best single fraction correlation coefficients. For this analysis, the time
shift found for this single fraction is used.
In a last step, the norm of the best correlation coefficient for each direction of the three
patients was plotted against the mean amplitude of the corresponding Calypso data, taken
from table 4.1. The correlation between these two parameters was assessed.
4.3 Results
4.3.1 Motion quantification
4.3.1.1 Overall displacement, midline changes and motion amplitude
The distribution of overall intrafractional centroid displacements relative to the initial mid-
line for all patients can be seen as a boxplot in fig. 4.4. The corresponding means and
standard deviations are listed in table 4.1. The mean values of the unidirectional displace-
ments are near zero (absolute value below 0.5mm) for the majority of cases, as it is expected
for a periodic breathing motion. The norm of the 5 larger deviations are between 0.6mm
and 1.9mm. These values indicate a change in the motion midline. The three-dimensional
displacement, whose values are not dominated by the compensation of positive and negative
position values, show mean values between 1.2 and 4.6mm with standard deviations from
0.7mm to 2.6mm.
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Table 4.1: Results of beacon centroid motion evaluation for all patients. For amplitude and
breathing frequency, the standard deviations describe the interfractional changes. The motion
directions related to the highlighted amplitudes were used for breathing frequency determination.
The motion amplitudes of patients 3 and 7 are too small to determine a breathing frequency.
Abbreviations: RUL: right upper lobe, LUL: left upper lobe, RML: right middle lobe.
1Calculated using eq. (4.2b).
2Calculated using eq. (4.3b).
Patient P1 P2 P3 P4 P5 P6 P7
Tumor position RUL LUL LUL RML LUL RML RML
Intrafractional
displacement [mm]
Lat Mean 0.0 -0.2 0.1 0.4 0.4 0.2 0.4SD 0.9 0.9 0.6 1.5 0.8 2.2 0.7
Long Mean 0.6 -0.1 0.3 0.7 0.1 -1.0 0.4SD 3.3 0.6 0.7 2.6 0.8 2.4 0.8
Vert Mean -1.9 0.1 0.0 0.1 0.1 -0.6 0.0SD 3.2 1.2 0.5 0.7 2.2 1.7 0.7
3D Mean
1 4.6 1.5 0.9 2.8 2.1 3.4 1.2
SD 2.6 0.7 0.6 1.5 1.3 1.9 0.7
Intrafractional midline
motion [mm]
Lat Mean 0.0 -0.2 0.1 0.4 0.4 0.2 0.4SD 0.4 0.4 0.5 0.9 0.6 1.9 0.7
Long Mean 0.6 -0.1 0.4 0.7 0.2 -1.0 0.4SD 2.5 0.5 0.7 1.0 0.6 1.9 0.7
Vert Mean -1.5 0.1 0.0 0.1 0.1 -0.6 0.0SD 2.6 0.6 0.5 0.5 1.4 1.6 0.6
3D Mean
2 3.4 0.8 0.8 1.4 1.4 2.9 1.0
SD 2.0 0.4 0.7 1.0 0.9 1.7 0.7
Amplitude around
current midline [mm]
Lat Mean 0.9 1.1 0.4 1.4 0.8 1.6 0.3SD 0.2 0.3 0.1 0.3 0.2 0.3 0.1
Long Mean 3.1 0.5 0.2 3.2 0.4 2.1 0.7SD 0.6 0.1 0.0 0.5 0.2 0.3 0.2
Vert Mean 2.7 1.6 0.3 0.5 2.2 0.7 0.5SD 0.3 0.2 0.0 0.1 0.7 0.2 0.1
3D Mean 4.0 2.0 0.5 3.4 2.3 2.8 0.9SD 0.6 0.3 0.1 0.5 0.7 0.3 0.2
Frequency
[breath/min]
Mean 15 23 - 13 10 24 -
SD 1 1 - 1 1 3 -
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Figure 4.4: Beacon centroid displacements for all patients in three directions calculated as
deviations from the initial midline for all fractions. The box indicates the values between 25%
and 75% of the motion data and the vertical line within the box marks the median. To exclude
outliers, the whiskers cover only 99% of the data.
The intrafractional changes of the motion midline are shown in table 4.1 as well. Here
the unidirectional means range from −1.5mm to 0.7mm with standard deviations between
0.4 and 2.6mm. Two different patterns of midline changes can be seen in fig. 4.1. The
longitudinal midline changes are periodic for the fraction of patient 1 in (a) and for the
displayed fraction of patient 6 the midline drifts towards negative values (b). For the three-
dimensional midline changes mean values between 0.8 and 3.4mm with standard deviations
between 0.4 and 2.0mm were measured.
The mean amplitudes around the current midline are presented in table 4.1, too. For
two of the seven patients all amplitudes, including the three-dimensional one, are below
1mm. For the other five patients the maximum unidirectional amplitude appears either in
the longitudinal or in the vertical direction, as highlighted in the table. These maximum
amplitudes are between 1.6 and 3.2mm. Three-dimensional amplitudes range from 0.5mm
to 4.0mm. The standard deviation for all amplitudes represent the interfractional change
of motion amplitudes, which is small with all values well below 1mm.
4.3.1.2 Breathing frequency
Breathing frequencies were determined from the unidirectional motion data with the largest
amplitude per patient, as highlighted in table 4.1. The fourier transforms lead to power
spectra like the one shown in fig. 4.5. In this figure, a power spectrum of lateral motion
of one fraction of patient 2 is shown. This spectrum is not used for the determination of
breathing frequency, because it is not the dominant motion direction. But it shows another
motion aspect, which can be seen best in lateral spectra: a second peak around 1.3Hz
representing motion induced by heart beat. The mean breathing frequencies lie between
0.4 and 0.17Hz equivalent to a range of 10 breath/min to 24 breath/min. The standard
deviation representing the interfractional change of the fractions mean frequency is between
4 and 13% of the mean.
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Figure 4.5: Power spectrum of the lateral motion of one fraction from patient 2. The smaller
peak at around 1.3Hz results from heart beat.
4.3.1.3 Motion differences between beam time and adjacent beam pauses
Differences between consecutive motion patterns can be large, as shown in fig. 4.6 for pa-
tient 1. The standard deviations have differences up to 2.1mm in longitudinal and up to
4.2mm in vertical direction. The lateral deviations are small, as the motion amount in lat-
eral direction is small in general. The differences in mean midline position are up to 7.0mm
in longitudinal and up to 9.1mm in vertical direction.
To evaluate, if these large deviations arise from a systematic difference between patient
motion during beam-on phases and beam pauses, the vertical motion of the two fractions
from patient 1 showing the largest deviations is shown in fig. 4.7. For fraction 1 in fig. 4.7(a),
the periodic breathing pattern is superimposed by a periodic motion pattern, with a larger
cycle duration. This motion pattern leads to motion shifted to the negative vertical direction
in some beam pauses, but it fits not perfectly to the periodicity of beam-on and beam-off
phases. Thus it is unlikely that it results from a voluntary movement or change in breathing
pattern of the patient recognizing the beam-on phases. In fraction 10, depicted in fig. 4.7(b),
the superimposed motion pattern is different in cycle time but with some similarities in the
pattern itself.
The patient with the second large 3D motion amplitude (patient 4) is chosen for this eval-
uation, too. The obtained differences in standard deviations and midline positions are very
small. For all fractions and motion directions the differences in standard deviations are be-
low 1mm, while the mean midline position deviates not more than 2mm between adjacent
time intervals.
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Figure 4.6: Results for the evaluation of differences in motion amount and patterns between
each beam pause and the beam-on phases prior and after the specified pauses for patient 1.
Deviations in overall standard deviations are shown (a) as well as deviations in mean midline
position (b). Both legends are valid for all images.
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Figure 4.7: Vertical motion for fraction 1 (a) and fraction 10 (b) of patient 1. The shaded
areas indicate the beam-on times.
4.3.2 Inter-transponder variations
4.3.2.1 Intrafractional changes
The six patients show very diverse results in the intrafractional variations of inter-transpon-
der distances, see fig. 4.8. For three patients (3, 6 and 7) nearly all SDs of inter-transponder
distances lie below 1mm for all three directions. For patients 2 and 4 there are SDs between
1 and 2mm in longitudinal direction for two transponder pairs, while for patient 1 there
are values of above 3mm of SD for two transponder pairs in longitudinal direction. The
corresponding mean 3D inter-transponder distances for patient 1 are 6.8 and 6.0 cm. Only
the SDs in longitudinal direction show values of above 1mm, hence they were studied further.
No correlation of the longitudinal SDs with the corresponding mean 3D inter-transponder
distance per fraction was found (Pearson’s correlation coefficient r=0.42), see fig. 4.9(a). The
same was shown for the relation between the longitudinal SDs and the mean 3D centroid’s
amplitude (r=0.49), see fig. 4.9(b). A much stronger correlation (r=0.83) was found for the
relation between the longitudinal SDs and the product of the prementioned parameters, see
fig. 4.10. All correlation coefficients are accompanied with a p < 0.01.
4.3.2.2 Interfractional changes
A decrease was found for the beacon triangle area over the whole treatment course for
all patients, see fig. 4.11. The extent of decrease differs from patient to patient. Using
the data from the linear regression, a decrease of 5.1% and 5.9% was found for the two
hypofractionated patients. For the conventionally fractionated IMRT patients the decrease
range from 6.6% for patient 4 to 41.5% for patient 7. The determination of beacon triangle
area from CT data was made for patients 3 and 7, the two patients with the largest decrease
in triangle area determined from the Calypso data. As can be seen in fig. 4.12, for all
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Figure 4.8: Standard deviations of the lateral, longitudinal and vertical inter-transponder dis-
tances for all fractions of each patient.
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Figure 4.9: Standard deviations of longitudinal inter-transponder distances per fraction plot-
ted against mean 3D distance per fraction (a) and against mean 3D amplitude of the transponder
centroid motion per fraction (b). Additionally the graphs of linear regressions are shown. It can
be seen, that the linear correlation of the respective data pairs is weak.
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Figure 4.10: Standard deviations of longitudinal inter-transponder distances per fraction plot-
ted against the product of mean 3D inter-transponder distance and mean 3D amplitude of the
transponder centroid motion per fraction. A strong correlation can be seen. Additionally the
linear regression is depicted.
days with corresponding data the triangle areas determined with both methods are in good
agreement. The Calypso value lies always inside the error region of the value calculated using
the CT data set. This error region was calculated from the inaccuracy which is expected for
manual read out of beacon positions in the CT slices. Here this inaccuracy was estimated
with half of the pixel size in all directions.
The interfractional changes in inter-transponder distances resulting in such decrease in the
area of the beacon triangle can be very heterogeneous in one patient. Two examples are
shown in fig. 4.13. For patient 6 can be seen, that two transponder distances decrease, while
one distance increases over time. For patient 7 a shrinkage of the inter-transponder distance
of 8mm for two transponder pairs over the whole treatment can be found. These pairs had an
initial 3D distance of 3.7 and 4.5 cm. This is the patient with the largest slopes in the linear
regression of the transponder distances against the day after first fraction, namely −0.25mm
per day for one transponder pair and −0.24mm for another. The calculation of this slope
for all transponder pairs in all patients lead to an average shrinkage of 3D inter-transponder
distances of (−0.04± 0.09)mm per day. This mean slope with large standard deviation
reflect the very heterogeneous situation between patients and even between transponders in
the same patient, with some transponder distances even growing over time.
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Figure 4.11: Mean and standard deviation (depicted by error bars) of the triangle area spanned
by the three transponders for all fractions of all patients. In addition the graph of the linear
regression is shown for better visualization of the trend. Each vertical axis has a range of 2 cm2.
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4.3.3 Correlation between internal and external motion
The correlation coefficients in dependence on time shifts are shown in fig. 4.14. For all
patients and motion directions the pattern of one period of a sinusoidal function can be seen
as effect of the periodic character of both underlying data sets.
The numerical results of the correlation analysis between the Calypso centroid motion and
the changes in abdominal circumference detected by the Anzai belt are shown in table 4.2.
The mean correlation coefficients are very heterogeneous, both between patients and be-
tween motion directions. Without regarding a phase shift between the monitored motion
data, only the longitudinal beacon centroid motion of patient 6 shows strong correlation
(|r| ≥ 0.8) with the Anzai signal. Taking possible phase shifts into account, the best mean
correlation coefficients for patient 5, 6 and 7 are 0.82 for the vertical motion, -0.85 for the
longitudinal motion and 0.57 for the vertical motion, respectively. The sign of the correla-
tion coefficient gives the direction of the relation between internal and external motion. For
these three values is the relation as follows: positive sign of r for vertical direction means
an inhalation causing increase of chest circumference is accompanied with a transponder
centroid motion in anterior direction, while the negative r for longitudinal motion describes
a caudal transponder centroid motion for inhalation.
In table 4.2 the best single fraction correlation coefficients are shown for completeness.
These single fraction data are determined with time shifts, too. These time shifts are
not listed, as they differ only slightly from the time shifts determined for the best mean
correlation coefficients. In most cases, this best single fraction correlation is much stronger,
than the best mean correlation. This is not caused by averaging effects due to different
time shifts for each fraction. The time shifts for different fractions of one patient show no
large differences. Large discrepancies between best mean correlation coefficients and best
single fraction correlation coefficients are an effect of the outlying character of the best single
fraction in comparison to the others.
In fig. 4.14 mean values and standard deviations are depicted, only. The development of
the correlation coefficient from fraction to fraction, all gathered at the time shift of the best
mean r, is shown in fig. 4.15 for the vertical Calypso motion of patient 5 and the longitudinal
motion of patient 6, as they are the only ones with a strong mean correlation coefficient.
No interfractional trend can be seen. For both patients nearly all fractions lie in a band of
correlation coefficients with a width of 0.2, the outliers go down until 0.54 for patient 5 and
until −0.76 for patient 6.
For the single fraction correlation analysis the following two data sets were used: fraction 6
of patient 5 (vertical direction) and fraction 19 of patient 6 (longitudinal direction), as these
are the fractions with the largest single fraction correlation (r = 0.94, resp. r = −0.94).
For patient 7 no fraction with a strong correlation was found. The variations with time can
be seen in fig. 4.16. They show no trend in time but variations between 0.90 and 0.98 for
patient 5 and between −0.73 and −0.99 for patient 6.
In fig. 4.17, the norm of the best mean correlation coefficient is plotted against the cor-
responding mean Calypso centroid amplitude for all directions of the three patients. The
data is shown together with a linear regression. This linear regression is accompanied with
a correlation coefficient of 0.81 (p < 0.01). This indicates a strong relationship between
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Table 4.2: Results of the correlation analysis between internal and external measured motion.
The correlation coefficients are highlighted with coloured background:
red: weak correlation (|r| < 0.5), yellow: moderate correlation (0.5 ≤ |r| < 0.8), green:
strong correlation (|r| ≥ 0.8). Best single fraction correlation coefficients are listed without the
corresponding time shifts.
P5 P6 P7
Lat
Mean r without time shift 0.00 -0.67 -0.30
Best mean r -0.63 -0.67 -0.32
Corresponding time shift Absolute [s] 1.40 0.00 -0.15Part of breathing cycle [%] 22.2 0.0 5.6
Best single fraction r -0.86 -0.88 -0.63
Long
Mean r without time shift -0.54 -0.85 0.45
Best mean r -0.64 -0.85 0.54
Corresponding time shift Absolute [s] 0.55 0.00 -0.20Part of breathing cycle [%] 8.7 0.0 7.4
Best single fraction r -0.89 -0.94 0.78
Vert
Mean r without time shift 0.65 -0.18 0.57
Best mean r 0.82 -0.36 0.57
Corresponding time shift Absolute [s] 0.60 -0.40 0.00Part of breathing cycle [%] 9.5 16.0 0.0
Best single fraction r 0.94 0.56 0.79
the Calypso motion amplitude and the correlation of internal centroid motion and external
chest motion: the larger the internal motion amplitude, the larger the correlation between
internal and external motion.
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Figure 4.14: Correlation coefficients between the three-dimensional Calypso data and the one-
dimensional Anzai signal. Mean values with standard deviations over all fractions are shown.
They are plotted against the time shift between the corresponding signals, used for calculation.
The time scale at the horizontal axis covers the mean duration of one breathing cycle for each
patient. Data for patient 5, 6 and 7 are shown in (a), (b) and (c), respectively.
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Figure 4.15: Correlation coefficients for all fractions between Anzai data and Calypso data
for patients 5 (a) and 6 (b), using the motion direction with largest correlation, only. For all
fractions of each patient the time shift corresponding to best mean r is used, as given in table 4.2.
Gaps in (b) result from the excluded fractions.
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Figure 4.16: Intrafractional variation of the correlation coefficent between Anzai data and
Calypso data. The correlation is calculated in a sliding window of 3 mean breathing cycle
durations each starting at the depicted time point (horizontal axis) after start of irradiation.
For patients 5 and 6 the fraction with the largest single fraction r is chosen. For patient 5 the
vertical motion direction of fraction 6 is used, with a corresponding time shift of 0.45 s (a). For
patient 6 the longitudinal motion direction of fraction 19 is used, with a corresponding time
shift of 0.00 s (b).
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Figure 4.17: Plot of the norm of the best mean correlation coefficient against the correspond-
ing mean amplitude of the beacon centroid for all three directions.
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4.4 Discussion
4.4.1 Motion quantification
Besides the pure motion quantification, the correlation between motion amount and tumor
localization was studied in some cases, e.g. using orthogonal radiographs (Stevens et al.,
2001; Seppenwoolde et al., 2002), an MR scanner (Plathow et al., 2004) or multiple CT scans
(van Sörnsen de Koste et al., 2003). Two of these analyses show tumor motion amplitude
to be larger the nearer the tumor position is to the diaphragm (increasing for the locations
upper lobe, middle lobe, lower lobe). The patient cohort used in this thesis contains only
seven patients, four with upper lobe and three with middle lobe tumors. Due to that, the
derived results are compared with published data for upper and middle lobe tumors, if not
stated different. In this thesis the amplitude is defined as distance between midline and
inhale or exhale peak, respectively. In the publications used for data comparison, a peak-
to-peak amplitude is used. Therefore the current results are doubled for comparison.
Published data for image based breathing motion analysis shows similar values for mo-
tion amplitudes and breathing frequencies as found here with the electromagnetic system.
An analysis using respiration correlated cone-beam CT (Bissonnette et al., 2009) reports
on mean 3D amplitudes extracted from 6 CTs per patient. Considering only the 11 pa-
tients with tumors in an upper or middle lobe in this publication, a mean 3D amplitude of
(3.7± 3.2)mm can be calculated. The corresponding value for our data is (4.5± 2.5)mm.
Mean values for unidirectional intrafractional motion, determined from lung marker motion
detected fluoroscopically 30 times a second are reported by (Seppenwoolde et al., 2002).
Therefore the peak-to-peak amplitude was determined for each breathing cycle and then
averaged, considering only the 13 patients with tumors in an upper or middle lobe the
following values are valid: lateral (1.2± 0.9)mm, longitudinal (3.2± 3.2)mm and verti-
cal (2.6± 2.2)mm. The corresponding values determined in this thesis are (1.8± 1.0)mm,
(2.9± 2.6)mm and (2.4± 1.9)mm. Determination of the average value of the largest inhale-
to-exhale difference during the setup procedure using the same marker detection method
as Seppenwolde et al. for 21 patients results in distances of (8.2± 6.5)mm in lateral,
(10.7± 8.6)mm in longitudinal (8.8± 7.0)mm in vertical direction (Shirato et al., 2006).
The localizations of these tumors are not specified, hence there can be lower lobe tumors
integrated, leading to more pronounced motion. Our data for complete intrafraction mo-
tion show smaller values: lateral (4.7± 2.3)mm, longitudinal (7.9± 5.8)mm and vertical
(6.6± 4.5)mm. For the 13 patients in (Seppenwoolde et al., 2002) breathing frequencies
are calculated to range from 13 breath/min to 22 breath/min with a mean and standard
deviation of (18± 2) breath/min, the seven patients evaluated here show similar breathing
frequencies: a range of 10 breath/min to 24 breath/min and a mean and standard deviation
of (17± 6) breath/min.
Intrafractional changes in the motion midline can be large, as shown here. The largest
mean difference between intrafactional 3D midline position and the fraction specific initial
midline is determined to 3.4mm for patient 1. In the same patient, the largest difference in
unidirectional mean midline position between two consecutive intervals of 20 s was found to
be 9.1mm in vertical direction. (Guckenberger et al., 2007) reported on maximum longitu-
dinal drift in mean tumor position for repeated 4D CT scans of 6.9mm for one lower lobe
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tumor within 30min. These results have to be considered if gating or tracking of the tumor
during the irradiation shall be performed. It has to be ensured that the used gating window
remains in the planned relation to the tumor position. For motion tracked irradiation, it
has to be decided for each individual patient if the motion prediction, needed because of
system latencies, can deal with the patient’s irregular breathing pattern.
Interfractional changes of tumor midline can not be evaluated with our data, because the
Calypso System was not used for patient positioning in the trial. All calculations in this
thesis are relative to a fraction specific initial midline. But there is published data indicating
remarkable interfractional variations of mean tumor position relative to the bony anatomy.
This data indicates the necessity of a patient positioning procedure, which is based on the
actual tumor position and not on any external marker or landmark. Variations in mean
tumor position from fraction to fraction are reported to be up to 18mm in longitudinal
direction and up to 24mm in lateral and vertical direction, determined from the planning
4D CT and a repeated one after 15 fractions (Schmidt et al., 2013). (Sonke et al., 2008)
calculated interfractional variations of the time-weighted mean tumor position of 40 patients
using a median number of nine 4D CBCT data sets per patient. The group systematic
error (one standard deviation) was determined to 1.6mm in lateral direction, 3.9mm in
longitudinal direction and 2.8mm in vertical direction. The random error was found to be
of the same size. (Juhler Nøttrup et al., 2007) analyzed interfractional changes in exhale
positions of a box with infrared markers on the patient’s chest for 11 patients, the median
value of interfraction span in these positions was calculated to 14.8mm with a range of
5.5mm to 31.0mm.
4.4.2 Inter-transponder variations
Longitudinal inter-transponder distances vary due to intrafraction breathing motion with an
SD of up to 3mm. This variation depends on the combination of inter-transponder distance
and overall motion amount. The motion amount for each patient is unknown before the
transponder implantation, so the inter-transponder distances should be as small as possible
enclosing the whole tumor, while the transponder centroid should be as close to the tumor
centroid as possible for good representation of tumor motion. Some implications on marker
positions for different tumor locations in the lung are made by (Smith et al., 2011) evaluating
tissue motion around tumors in 4D CTs.
There is a general decrease in inter-transponder distances over the course of radiation treat-
ment. The spanned triangle area of the transponders shrank between 6.6% and 41.5% for
the conventional fractionated patients. Two patients got additional chemotherapy, how-
ever, no statement can be made about the effect of the combination of radiotherapy and
chemotherapy. The patient with the concurrent chemotherapy was excluded from this part
of investigation, because of only two trackable transponders, as described before and the
patient with the chemotherapy before the irradiation showed a decrease of 17.6% which fits
in the decrease of the other patients.
To compare the shrinkage with published data, the distances itself have to be reviewed.
Their variations are larger than reported for interfractional changes of fiducial marker dis-
tances by (Imura et al., 2005). They report on inter-marker distances during one to two
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weeks of treatment and follow up measurements until 40 days after the first fraction. Thereby
80% of the measured distances differ maximum 1mm from the initial distances, while 95%
are within 2mm. The corresponding values for the changes in mean fraction distances
for the Calypso transponders in this work are much less with 45% and 75% for 1mm
and 2mm, respectively. The changes in inter-transponder distances are an indicator for
geometry variations in the surrounding lung tissue. This can lead to a deviation of the
relationship of transponder centroid and tumor centroid from the situation found in the
planning CT, especially, if the shrinkage is not uniform for all inter-transponder distances
in a patient. (Roman et al., 2012) report on mean interfractional marker-to-tumor cen-
troid displacements of (4± 2)mm in lateral, (4± 3)mm in longitudinal and (3± 2)mm in
vertical direction, measured in weekly 4D CBCTs over seven weeks in seven patients. The
corresponding 3D distance change is (5± 3)mm. This indicates a necessity of a regular
evaluation of the inter-transponder distances, if a conventional fractionation is performed.
The Calypso System provides a daily transponder geometry check to enable this evaluation.
Due to geometry changes, a new CT and treatment planning procedure can be necessary not
only to customize the irradiation fields to the tumor but also for an update of transponder
positions relative to the tumor. To be aware of these changes, a weekly CT scan can be
recommended.
For our data on shrinkage of the beacon triangle, no data on simultaneously changes in
GTV volume is available. But it can be assumed that the GTVs are shrinking, too, like
described in the aforementioned studies (Kupelian et al., 2005; Britton et al., 2007). It is
not clear if this data allows for an early estimation of the benefit, the patient got through
the radiotherapy, during the course of treatment. Although the change in tumor volume
is a standard measure to quantify therapy response in general, see e.g. (Eisenhauer et al.,
2009), it is not necessarily correlated to a longer overall survival time. For example, no
correlation between tumor shrinkage during chemotherapy assessed with repeated CT data
sets and the overall survival can be found for NSCLC patients (Knollmann et al., 2014).
For radiotherapy it is shown that the metabolic information of the treated tumor provided
by PET imaging is superior to the pure morphological information in the CT data set in
predicting the survival time of NSCLC patients in follow up care (Manus et al., 2003).
One possible side effect due to irradiation of healthy lung tissue is a pneumonitis, which
can lead to a persistent lung fibrosis, see e.g. (Sauer, 2010). A lung fibrosis is characterized
by the exchange of normal lung tissue by fibrotic tissue (like scarred tissue) which is less
elastic and not able to provide for the gas exchange and is thereby a very serious late side
effect. The standard deviations of the transponder distances show no trend with time, thus
no statement about early changes in lung tissue elasticity because of side effects over the
course of treatment can be made.
4.4.3 Correlation between internal and external motion
For two of the three regarded patients a strong correlation between one coordinate of the
internal transponder centroid motion and the changes in chest circumference can be found.
This is the vertical coordinate for patient 5 and the longitudinal one for patient 6. The
best mean correlation coefficients per motion direction are accompanied with a time shift
between the internal and external signal. This time shift range from −0.6 s to 1.4 s. These
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time shifts are too large to be caused by the different beam status detection and sample
rates of the two motion detection systems. An anatomical or physiological reason seems to
be probable as other publications report on the same effect with different motion detection
methods. (Tsunashima et al., 2004) reports on time shifts of up to 1 s for a laser surface
scanner as external breathing motion indicator and fluoroscopic images acquired after the
patient setup in a study with 32 patients suffering from tumors in lung, liver or esophagus.
(Korreman et al., 2006) analyzed the correlation of internal fiducial markers detected with
19 cine fluoroscopies in seven lung patients acquired over 40 s each and the motion of a box
with infrared markers on the patient’s abdomen. They report on time shifts up to 1.9 s.
Their best correlation coefficients lie between 0.49 and 0.99, the norm of the best single
fraction correlation coefficients in the current analysis is similar with values between 0.56
and 0.94.
Even if the best mean correlation is strong, this correlation varies intrafractional and in-
terfractional as shown here and demonstrated in (Ionascu et al., 2007). Because of that, a
frequent update of the correlation model has to be performed if the external signal shall be
used for motion management like proposed e.g. by (Wu et al., 2008) for gating or integrated
in the CyberKnife system for tracking, see (Sayeh et al., 2007). If infrared markers on the
patient’s skin are used, the stability of internal/external correlation can also be increased
by the use of a combined signal from multiple markers, see (Yan et al., 2006).
The correlation has shown to be stronger for larger internal motion amplitudes. This can
be explained by the problem of low signal to noise ratio of the Calypso signal for small
amplitudes. In these cases, the respiratory induced motion is not dominant enough to drive
the correlation analysis, as presented for fluoroscopic signals by (Ionascu et al., 2007).
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In this thesis, investigations on inter- and intrafractional motion of prostate and lung cancer
patients during radiotherapy were made. The used patient data was collected during two
clinical trials performed at dkfz. For all 32 patients, real-time motion data of implanted
passive resonant circuits was detected continuously during the treatment with an electro-
magnetic tumor tracking system, the Calypso System by Varian Medical Systems Inc. Based
on this motion data, different evaluations were performed. For both tumor sites the overall
motion amount and motion pattern characteristics were studied, while the other evalua-
tions were diverse. The analysis of the prostate data focused on the arising consequences
I) for margin concepts, if MV CBCTs are used for patient positioning and no intrafraction
motion management is available and II) for the delivered dose distributions in the indi-
vidual patients studied here. For the new application of electromagnetic tracking in lung
radiotherapy, which has not been studied before, evaluations were made to assess inter- and
intrafractional changes of the geometry of implanted transponders, which can compromise
the use of the transponder centroid motion as tumor motion surrogate. Additionally, a
correlation analysis between transponder centroid motion and chest motion was done for
three lung cancer patients, because chest motion is often used as external surrogate for lung
tumor motion in gated radiotherapy.
Prostate
Derived margins for compensation of the combination of MV CBCT based patient setup
and intrafraction motion for treatment fractions lasting for 9min ranges from 7mm to
9mm dependent on the image registration strategy. However, these margins would have to
be enlarged for clinical application due to other uncertainties. A thereby enlarged irradiated
volume of organs at risk with high prescription doses up to 80Gy, desired in modern prostate
radiotherapy, will increase the probability of severe side effects and therefore these margins
are not clinically applicable.
Evaluating the dosimetric consequences of intrafraction motion for individual patients with
the experimentally validated 4D dose accumulation method based on motion dependent
target points, large dose perturbations in single fractions can be found. Due to averaging
effects, a remarkable dosimetric consequence on the clinical target volume for the whole
treatment course is determined for one patient, only. The irradiation concept was thereby
an integrated boost irradiation, which results in an inner high dose region (boost volume)
with a lower dose margin of 7mm. This margin seems to be sufficient for 20 of 21 patients
to compensate for intrafraction motion, but the additional uncertainties from interfraction
motion was not accounted for during the dose reconstruction.
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These investigations lead to the conclusion, that an adaptive approach for motion manage-
ment in prostate radiotherapy is necessary in particular, when a hypofractionated therapy is
performed meaning less fractions with higher single fraction doses, as discussed for prostate
due to radiobiological reasons. The aim of adaptive motion management is the reaction on
motion information acquired during the irradiation, enabling the reduction of margin sizes
without compromising the dose delivered to the tumor. Different methods of adaptive radio-
therapy are very diverse in effort regarding both technical equipment and additional time for
preparation, the treatment procedure itself and quality assurance. The simplest way would
be a repeated positioning procedure using image guidance during the therapy to enable the
compensation of prostate drifts. If real-time motion data is available, a threshold based
repositioning can be applied in combination with a gating like approach, where the beam is
disabled, when one of the characteristic prostate spikes is occurring. Good correlations be-
tween the mean prostate displacement and the deviations in all dosimetric endpoints studied
here give rise to the assumption that these motion management procedures will reduce the
dose effects remarkable. More complex methods of couch or MLC based prostate tracking
may also considerably reduce these dose perturbations as was demonstrated experimentally,
see (Menten et al., 2012; Pommer et al., 2013).
Lung
In general there are two motion components of lung tumors, the periodic breathing motion
around a mean position (called midline) and the change of this midline over time. The lung
cancer patients studied here show intrafractional midline motion of the same size as the
breathing amplitude. This intrafractional midline motion compromises the use of margins
based on the motion information in the 4D CT, because it means that the mean tumor
position around which the margin is defined is not stable over time. As the midline motion
is not necessarily periodic or predictable prior to the fraction, a real-time motion monitoring
enabling patient specific motion management seems to be essential.
The analysis of transponder centroid motion during adjacent time intervals shows that the
quality of motion prediction, required for tumor tracking systems with long latency time
between motion detection and actual reaction on it, will highly depend on the single patient.
In these cases it can be of advantage to perform a less complex tracking, like a tracking of the
midline position, while the periodic breathing motion is taken into account by a margin.
Considering the results on the intra- and interfractional variations in transponder geome-
try (e.g. SDs of the intrafractional longitudinal inter-transponder distances of up to 3mm),
two recommendations for transponder implantation can be given from our data. First they
should be arranged around the tumor regularly to ensure best representation of tumor po-
sition and second, they should be as close together as possible to reduce the probability
of large intrafractional variations. Looking at interfractional changes, a continuous shrink-
age of the spanned transponder triangle can be observed. Together with the finding that
the corresponding inter-transponder distances are shrinking differently and some are even
growing, a monitoring of the internal geometry both between transponders and between
transponder centroid and tumor should be performed on a regular basis, for example by
acquiring a weekly CT scan.
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The correlation analysis between beacon centroid motion and changes in chest circumference
leads to three findings that have to be considered, when the external signal is used as tumor
surrogate motion in motion management. First, there are phase shifts between the internal
and the external signal, second, the correlation slightly changes from fraction to fraction
and third, even during one fraction the external/internal correlation changes. This lead to
the conclusion, that a procedure of frequent control and if required an adaption of the used
correlation model should be established.
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